Motif 315 (n=89)
Position-wise Probabilities
Download
uniprot | genes | site | source | protein | function |
---|---|---|---|---|---|
A2A288 | ZC3H12D | S329 | ochoa | Probable ribonuclease ZC3H12D (EC 3.1.-.-) (MCP-induced protein 4) (Transformed follicular lymphoma) (Zinc finger CCCH domain-containing protein 12D) (p34) | May regulate cell growth likely by suppressing RB1 phosphorylation (PubMed:19531561). May function as RNase and regulate the levels of target RNA species (Potential). In association with ZC3H12A enhances the degradation of interleukin IL-6 mRNA level in activated macrophages (PubMed:26134560). Serve as a tumor suppressor in certain leukemia cells (PubMed:17210687). Overexpression inhibits the G1 to S phase progression through suppression of RB1 phosphorylation (PubMed:19531561). {ECO:0000269|PubMed:17210687, ECO:0000269|PubMed:19531561, ECO:0000269|PubMed:26134560, ECO:0000305}. |
A6NEL2 | SOWAHB | S258 | ochoa | Ankyrin repeat domain-containing protein SOWAHB (Ankyrin repeat domain-containing protein 56) (Protein sosondowah homolog B) | None |
H0YHG0 | None | S431 | ochoa | DnaJ homolog subfamily C member 14 (Nuclear protein Hcc-1) (SAP domain-containing ribonucleoprotein) | Binds both single-stranded and double-stranded DNA with higher affinity for the single-stranded form. Specifically binds to scaffold/matrix attachment region DNA. Also binds single-stranded RNA. Enhances RNA unwinding activity of DDX39A. May participate in important transcriptional or translational control of cell growth, metabolism and carcinogenesis. Component of the TREX complex which is thought to couple mRNA transcription, processing and nuclear export, and specifically associates with spliced mRNA and not with unspliced pre-mRNA. The TREX complex is recruited to spliced mRNAs by a transcription-independent mechanism, binds to mRNA upstream of the exon-junction complex (EJC) and is recruited in a splicing- and cap-dependent manner to a region near the 5' end of the mRNA where it functions in mRNA export to the cytoplasm via the TAP/NXF1 pathway. Associates with DDX39B, which facilitates RNA binding of DDX39B and likely plays a role in mRNA export. {ECO:0000256|ARBA:ARBA00054093}.; FUNCTION: Regulates the export of target proteins, such as DRD1, from the endoplasmic reticulum to the cell surface. {ECO:0000256|ARBA:ARBA00055510}. |
O00429 | DNM1L | S529 | ochoa | Dynamin-1-like protein (EC 3.6.5.5) (Dnm1p/Vps1p-like protein) (DVLP) (Dynamin family member proline-rich carboxyl-terminal domain less) (Dymple) (Dynamin-like protein) (Dynamin-like protein 4) (Dynamin-like protein IV) (HdynIV) (Dynamin-related protein 1) | Functions in mitochondrial and peroxisomal division (PubMed:11514614, PubMed:12499366, PubMed:17301055, PubMed:17460227, PubMed:17553808, PubMed:18695047, PubMed:18838687, PubMed:19342591, PubMed:19411255, PubMed:19638400, PubMed:23283981, PubMed:23530241, PubMed:23921378, PubMed:26992161, PubMed:27145208, PubMed:27145933, PubMed:27301544, PubMed:27328748, PubMed:29478834, PubMed:32439975, PubMed:32484300, PubMed:9570752, PubMed:9786947). Mediates membrane fission through oligomerization into membrane-associated tubular structures that wrap around the scission site to constrict and sever the mitochondrial membrane through a GTP hydrolysis-dependent mechanism (PubMed:23530241, PubMed:23584531, PubMed:33850055). The specific recruitment at scission sites is mediated by membrane receptors like MFF, MIEF1 and MIEF2 for mitochondrial membranes (PubMed:23283981, PubMed:23921378, PubMed:29899447). While the recruitment by the membrane receptors is GTP-dependent, the following hydrolysis of GTP induces the dissociation from the receptors and allows DNM1L filaments to curl into closed rings that are probably sufficient to sever a double membrane (PubMed:29899447). Acts downstream of PINK1 to promote mitochondrial fission in a PRKN-dependent manner (PubMed:32484300). Plays an important role in mitochondrial fission during mitosis (PubMed:19411255, PubMed:26992161, PubMed:27301544, PubMed:27328748). Through its function in mitochondrial division, ensures the survival of at least some types of postmitotic neurons, including Purkinje cells, by suppressing oxidative damage (By similarity). Required for normal brain development, including that of cerebellum (PubMed:17460227, PubMed:26992161, PubMed:27145208, PubMed:27301544, PubMed:27328748). Facilitates developmentally regulated apoptosis during neural tube formation (By similarity). Required for a normal rate of cytochrome c release and caspase activation during apoptosis; this requirement may depend upon the cell type and the physiological apoptotic cues (By similarity). Required for formation of endocytic vesicles (PubMed:20688057, PubMed:23792689, PubMed:9570752). Proposed to regulate synaptic vesicle membrane dynamics through association with BCL2L1 isoform Bcl-X(L) which stimulates its GTPase activity in synaptic vesicles; the function may require its recruitment by MFF to clathrin-containing vesicles (PubMed:17015472, PubMed:23792689). Required for programmed necrosis execution (PubMed:22265414). Rhythmic control of its activity following phosphorylation at Ser-637 is essential for the circadian control of mitochondrial ATP production (PubMed:29478834). {ECO:0000250|UniProtKB:Q8K1M6, ECO:0000269|PubMed:11514614, ECO:0000269|PubMed:12499366, ECO:0000269|PubMed:17015472, ECO:0000269|PubMed:17301055, ECO:0000269|PubMed:17460227, ECO:0000269|PubMed:17553808, ECO:0000269|PubMed:18695047, ECO:0000269|PubMed:18838687, ECO:0000269|PubMed:19342591, ECO:0000269|PubMed:19411255, ECO:0000269|PubMed:19638400, ECO:0000269|PubMed:20688057, ECO:0000269|PubMed:22265414, ECO:0000269|PubMed:23283981, ECO:0000269|PubMed:23530241, ECO:0000269|PubMed:23584531, ECO:0000269|PubMed:23792689, ECO:0000269|PubMed:23921378, ECO:0000269|PubMed:26992161, ECO:0000269|PubMed:27145208, ECO:0000269|PubMed:27145933, ECO:0000269|PubMed:27301544, ECO:0000269|PubMed:27328748, ECO:0000269|PubMed:29478834, ECO:0000269|PubMed:29899447, ECO:0000269|PubMed:32439975, ECO:0000269|PubMed:32484300, ECO:0000269|PubMed:33850055, ECO:0000269|PubMed:9570752, ECO:0000269|PubMed:9786947}.; FUNCTION: [Isoform 1]: Inhibits peroxisomal division when overexpressed. {ECO:0000269|PubMed:12618434}.; FUNCTION: [Isoform 4]: Inhibits peroxisomal division when overexpressed. {ECO:0000269|PubMed:12618434}. |
O14526 | FCHO1 | S372 | ochoa | F-BAR domain only protein 1 | Functions in an early step of clathrin-mediated endocytosis (PubMed:30822429). Has both a membrane binding/bending activity and the ability to recruit proteins essential to the formation of functional clathrin-coated pits. May regulate Bmp signaling by regulating clathrin-mediated endocytosis of Bmp receptors. Involved in the regulation of T-cell poliferation and activation (PubMed:30822429, PubMed:32098969). Affects TCR clustering upon receptor triggering and modulates its internalisation, playing a role in TCR-dependent T-cell activation (PubMed:32098969). {ECO:0000269|PubMed:20448150, ECO:0000269|PubMed:30822429, ECO:0000269|PubMed:32098969}. |
O15534 | PER1 | S1006 | ochoa | Period circadian protein homolog 1 (hPER1) (Circadian clock protein PERIOD 1) (Circadian pacemaker protein Rigui) | Transcriptional repressor which forms a core component of the circadian clock. The circadian clock, an internal time-keeping system, regulates various physiological processes through the generation of approximately 24 hour circadian rhythms in gene expression, which are translated into rhythms in metabolism and behavior. It is derived from the Latin roots 'circa' (about) and 'diem' (day) and acts as an important regulator of a wide array of physiological functions including metabolism, sleep, body temperature, blood pressure, endocrine, immune, cardiovascular, and renal function. Consists of two major components: the central clock, residing in the suprachiasmatic nucleus (SCN) of the brain, and the peripheral clocks that are present in nearly every tissue and organ system. Both the central and peripheral clocks can be reset by environmental cues, also known as Zeitgebers (German for 'timegivers'). The predominant Zeitgeber for the central clock is light, which is sensed by retina and signals directly to the SCN. The central clock entrains the peripheral clocks through neuronal and hormonal signals, body temperature and feeding-related cues, aligning all clocks with the external light/dark cycle. Circadian rhythms allow an organism to achieve temporal homeostasis with its environment at the molecular level by regulating gene expression to create a peak of protein expression once every 24 hours to control when a particular physiological process is most active with respect to the solar day. Transcription and translation of core clock components (CLOCK, NPAS2, BMAL1, BMAL2, PER1, PER2, PER3, CRY1 and CRY2) plays a critical role in rhythm generation, whereas delays imposed by post-translational modifications (PTMs) are important for determining the period (tau) of the rhythms (tau refers to the period of a rhythm and is the length, in time, of one complete cycle). A diurnal rhythm is synchronized with the day/night cycle, while the ultradian and infradian rhythms have a period shorter and longer than 24 hours, respectively. Disruptions in the circadian rhythms contribute to the pathology of cardiovascular diseases, cancer, metabolic syndromes and aging. A transcription/translation feedback loop (TTFL) forms the core of the molecular circadian clock mechanism. Transcription factors, CLOCK or NPAS2 and BMAL1 or BMAL2, form the positive limb of the feedback loop, act in the form of a heterodimer and activate the transcription of core clock genes and clock-controlled genes (involved in key metabolic processes), harboring E-box elements (5'-CACGTG-3') within their promoters. The core clock genes: PER1/2/3 and CRY1/2 which are transcriptional repressors form the negative limb of the feedback loop and interact with the CLOCK|NPAS2-BMAL1|BMAL2 heterodimer inhibiting its activity and thereby negatively regulating their own expression. This heterodimer also activates nuclear receptors NR1D1/2 and RORA/B/G, which form a second feedback loop and which activate and repress BMAL1 transcription, respectively. Regulates circadian target genes expression at post-transcriptional levels, but may not be required for the repression at transcriptional level. Controls PER2 protein decay. Represses CRY2 preventing its repression on CLOCK/BMAL1 target genes such as FXYD5 and SCNN1A in kidney and PPARA in liver. Besides its involvement in the maintenance of the circadian clock, has an important function in the regulation of several processes. Participates in the repression of glucocorticoid receptor NR3C1/GR-induced transcriptional activity by reducing the association of NR3C1/GR to glucocorticoid response elements (GREs) by BMAL1:CLOCK. Plays a role in the modulation of the neuroinflammatory state via the regulation of inflammatory mediators release, such as CCL2 and IL6. In spinal astrocytes, negatively regulates the MAPK14/p38 and MAPK8/JNK MAPK cascades as well as the subsequent activation of NFkappaB. Coordinately regulates the expression of multiple genes that are involved in the regulation of renal sodium reabsorption. Can act as gene expression activator in a gene and tissue specific manner, in kidney enhances WNK1 and SLC12A3 expression in collaboration with CLOCK. Modulates hair follicle cycling. Represses the CLOCK-BMAL1 induced transcription of BHLHE40/DEC1. {ECO:0000269|PubMed:24005054}. |
O43147 | SGSM2 | S123 | ochoa | Small G protein signaling modulator 2 (RUN and TBC1 domain-containing protein 1) | Possesses GTPase activator activity towards RAB32, RAB33B and RAB38 (PubMed:21808068, PubMed:26620560). Regulates the trafficking of melanogenic enzymes TYR, TYRP1 and DCT/TYRP2 to melanosomes in melanocytes by inactivating RAB32 and RAB38. Inhibits RAB32 and RAB38 activation both directly by promoting their GTPase activity and indirectly by disrupting the RAB9A-HPS4 interaction which is required for RAB32/38 activation (PubMed:26620560). {ECO:0000269|PubMed:21808068, ECO:0000269|PubMed:26620560}. |
O43248 | HOXC11 | S210 | ochoa | Homeobox protein Hox-C11 (Homeobox protein Hox-3H) | Sequence-specific transcription factor which is part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis. Binds to a promoter element of the lactase-phlorizin hydrolase gene. |
O60292 | SIPA1L3 | S1667 | ochoa | Signal-induced proliferation-associated 1-like protein 3 (SIPA1-like protein 3) (SPA-1-like protein 3) | Plays a critical role in epithelial cell morphogenesis, polarity, adhesion and cytoskeletal organization in the lens (PubMed:26231217). {ECO:0000269|PubMed:26231217}. |
O60336 | MAPKBP1 | S1198 | ochoa | Mitogen-activated protein kinase-binding protein 1 (JNK-binding protein 1) (JNKBP-1) | Negative regulator of NOD2 function. It down-regulates NOD2-induced processes such as activation of NF-kappa-B signaling, IL8 secretion and antibacterial response (PubMed:22700971). Involved in JNK signaling pathway (By similarity). {ECO:0000250|UniProtKB:Q6NS57, ECO:0000269|PubMed:22700971}. |
P0C7X2 | ZNF688 | S131 | ochoa | Zinc finger protein 688 | May be involved in transcriptional regulation. |
P12882 | MYH1 | Y389 | ochoa | Myosin-1 (Myosin heavy chain 1) (Myosin heavy chain 2x) (MyHC-2x) (Myosin heavy chain IIx/d) (MyHC-IIx/d) (Myosin heavy chain, skeletal muscle, adult 1) | Required for normal hearing. It plays a role in cochlear amplification of auditory stimuli, likely through the positive regulation of prestin (SLC26A5) activity and outer hair cell (OHC) electromotility. {ECO:0000250|UniProtKB:Q5SX40}. |
P13535 | MYH8 | Y389 | ochoa | Myosin-8 (Myosin heavy chain 8) (Myosin heavy chain, skeletal muscle, perinatal) (MyHC-perinatal) | Muscle contraction. |
P14550 | AKR1A1 | S211 | ochoa | Aldo-keto reductase family 1 member A1 (EC 1.1.1.2) (EC 1.1.1.372) (EC 1.1.1.54) (Alcohol dehydrogenase [NADP(+)]) (Aldehyde reductase) (Glucuronate reductase) (EC 1.1.1.19) (Glucuronolactone reductase) (EC 1.1.1.20) (S-nitroso-CoA reductase) (ScorR) (EC 1.6.-.-) | Catalyzes the NADPH-dependent reduction of a wide variety of carbonyl-containing compounds to their corresponding alcohols (PubMed:10510318, PubMed:30538128). Displays enzymatic activity towards endogenous metabolites such as aromatic and aliphatic aldehydes, ketones, monosaccharides and bile acids, with a preference for negatively charged substrates, such as glucuronate and succinic semialdehyde (PubMed:10510318, PubMed:30538128). Functions as a detoxifiying enzyme by reducing a range of toxic aldehydes (By similarity). Reduces methylglyoxal and 3-deoxyglucosone, which are present at elevated levels under hyperglycemic conditions and are cytotoxic (By similarity). Involved also in the detoxification of lipid-derived aldehydes like acrolein (By similarity). Plays a role in the activation of procarcinogens, such as polycyclic aromatic hydrocarbon trans-dihydrodiols, and in the metabolism of various xenobiotics and drugs, including the anthracyclines doxorubicin (DOX) and daunorubicin (DAUN) (PubMed:11306097, PubMed:18276838). Also acts as an inhibitor of protein S-nitrosylation by mediating degradation of S-nitroso-coenzyme A (S-nitroso-CoA), a cofactor required to S-nitrosylate proteins (PubMed:30538128). S-nitroso-CoA reductase activity is involved in reprogramming intermediary metabolism in renal proximal tubules, notably by inhibiting protein S-nitrosylation of isoform 2 of PKM (PKM2) (By similarity). Also acts as a S-nitroso-glutathione reductase by catalyzing the NADPH-dependent reduction of S-nitrosoglutathione (PubMed:31649033). Displays no reductase activity towards retinoids (By similarity). {ECO:0000250|UniProtKB:P50578, ECO:0000250|UniProtKB:P51635, ECO:0000269|PubMed:10510318, ECO:0000269|PubMed:11306097, ECO:0000269|PubMed:18276838, ECO:0000269|PubMed:30538128, ECO:0000269|PubMed:31649033}. |
P14635 | CCNB1 | S35 | ochoa | G2/mitotic-specific cyclin-B1 | Essential for the control of the cell cycle at the G2/M (mitosis) transition. {ECO:0000269|PubMed:17495531, ECO:0000269|PubMed:17495533, ECO:0000269|PubMed:27030811}. |
P17677 | GAP43 | S131 | ochoa | Neuromodulin (Axonal membrane protein GAP-43) (Growth-associated protein 43) (Neural phosphoprotein B-50) (pp46) | This protein is associated with nerve growth. It is a major component of the motile 'growth cones' that form the tips of elongating axons. Plays a role in axonal and dendritic filopodia induction. {ECO:0000269|PubMed:14978216, ECO:0000269|PubMed:21152083}. |
P18031 | PTPN1 | S216 | ochoa | Tyrosine-protein phosphatase non-receptor type 1 (EC 3.1.3.48) (Protein-tyrosine phosphatase 1B) (PTP-1B) | Tyrosine-protein phosphatase which acts as a regulator of endoplasmic reticulum unfolded protein response. Mediates dephosphorylation of EIF2AK3/PERK; inactivating the protein kinase activity of EIF2AK3/PERK. May play an important role in CKII- and p60c-src-induced signal transduction cascades. May regulate the EFNA5-EPHA3 signaling pathway which modulates cell reorganization and cell-cell repulsion. May also regulate the hepatocyte growth factor receptor signaling pathway through dephosphorylation of MET. {ECO:0000269|PubMed:18819921, ECO:0000269|PubMed:21135139, ECO:0000269|PubMed:22169477}. |
P23193 | TCEA1 | S135 | ochoa | Transcription elongation factor A protein 1 (Transcription elongation factor S-II protein 1) (Transcription elongation factor TFIIS.o) | Necessary for efficient RNA polymerase II transcription elongation past template-encoded arresting sites. The arresting sites in DNA have the property of trapping a certain fraction of elongating RNA polymerases that pass through, resulting in locked ternary complexes. Cleavage of the nascent transcript by S-II allows the resumption of elongation from the new 3'-terminus. |
P31327 | CPS1 | S1193 | ochoa | Carbamoyl-phosphate synthase [ammonia], mitochondrial (EC 6.3.4.16) (Carbamoyl-phosphate synthetase I) (CPSase I) | Involved in the urea cycle of ureotelic animals where the enzyme plays an important role in removing excess ammonia from the cell. |
P41440 | SLC19A1 | S485 | ochoa | Reduced folate transporter (FOLT) (Cyclic dinucleotide:anion antiporter SLC19A1) (Folate:anion antiporter SLC19A1) (Intestinal folate carrier 1) (IFC-1) (Placental folate transporter) (Reduced folate carrier protein) (RFC) (hRFC) (Reduced folate transporter 1) (RFT-1) (Solute carrier family 19 member 1) (hSLC19A1) | Antiporter that mediates the import of reduced folates or a subset of cyclic dinucleotides, driven by the export of organic anions (PubMed:10787414, PubMed:15337749, PubMed:16115875, PubMed:22554803, PubMed:31126740, PubMed:31511694, PubMed:32276275, PubMed:36071163, PubMed:36265513, PubMed:36575193, PubMed:7826387, PubMed:9041240). Acts as an importer of immunoreactive cyclic dinucleotides, such as cyclic GMP-AMP (2'-3'-cGAMP), an immune messenger produced in response to DNA virus in the cytosol, and its linkage isomer 3'-3'-cGAMP, thus playing a role in triggering larger immune responses (PubMed:31126740, PubMed:31511694, PubMed:36745868). Mechanistically, acts as a secondary active transporter, which exports intracellular organic anions down their concentration gradients to facilitate the uptake of its substrates (PubMed:22554803, PubMed:31126740, PubMed:31511694). Has high affinity for N5-methyltetrahydrofolate, the predominant circulating form of folate (PubMed:10787414, PubMed:14609557, PubMed:22554803, PubMed:36071163, PubMed:36265513, PubMed:36575193). Also mediates the import of antifolate drug methotrexate (PubMed:22554803, PubMed:36071163, PubMed:7615551, PubMed:7641195, PubMed:9767079). 5-amino-4-imidazolecarboxamide riboside (AICAR), when phosphorylated to AICAR monophosphate, can serve as an organic anion for antiporter activity (PubMed:22554803). {ECO:0000269|PubMed:10787414, ECO:0000269|PubMed:14609557, ECO:0000269|PubMed:15337749, ECO:0000269|PubMed:16115875, ECO:0000269|PubMed:22554803, ECO:0000269|PubMed:31126740, ECO:0000269|PubMed:31511694, ECO:0000269|PubMed:32276275, ECO:0000269|PubMed:36071163, ECO:0000269|PubMed:36265513, ECO:0000269|PubMed:36575193, ECO:0000269|PubMed:36745868, ECO:0000269|PubMed:7615551, ECO:0000269|PubMed:7641195, ECO:0000269|PubMed:7826387, ECO:0000269|PubMed:9041240, ECO:0000269|PubMed:9767079}. |
P42684 | ABL2 | S618 | ochoa | Tyrosine-protein kinase ABL2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson tyrosine-protein kinase 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) | Non-receptor tyrosine-protein kinase that plays an ABL1-overlapping role in key processes linked to cell growth and survival such as cytoskeleton remodeling in response to extracellular stimuli, cell motility and adhesion and receptor endocytosis. Coordinates actin remodeling through tyrosine phosphorylation of proteins controlling cytoskeleton dynamics like MYH10 (involved in movement); CTTN (involved in signaling); or TUBA1 and TUBB (microtubule subunits). Binds directly F-actin and regulates actin cytoskeletal structure through its F-actin-bundling activity. Involved in the regulation of cell adhesion and motility through phosphorylation of key regulators of these processes such as CRK, CRKL, DOK1 or ARHGAP35. Adhesion-dependent phosphorylation of ARHGAP35 promotes its association with RASA1, resulting in recruitment of ARHGAP35 to the cell periphery where it inhibits RHO. Phosphorylates multiple receptor tyrosine kinases like PDGFRB and other substrates which are involved in endocytosis regulation such as RIN1. In brain, may regulate neurotransmission by phosphorylating proteins at the synapse. ABL2 also acts as a regulator of multiple pathological signaling cascades during infection. Pathogens can highjack ABL2 kinase signaling to reorganize the host actin cytoskeleton for multiple purposes, like facilitating intracellular movement and host cell exit. Finally, functions as its own regulator through autocatalytic activity as well as through phosphorylation of its inhibitor, ABI1. Positively regulates chemokine-mediated T-cell migration, polarization, and homing to lymph nodes and immune-challenged tissues, potentially via activation of NEDD9/HEF1 and RAP1 (By similarity). {ECO:0000250|UniProtKB:Q4JIM5, ECO:0000269|PubMed:15735735, ECO:0000269|PubMed:15886098, ECO:0000269|PubMed:16678104, ECO:0000269|PubMed:17306540, ECO:0000269|PubMed:18945674}. |
P43686 | PSMC4 | S19 | ochoa | 26S proteasome regulatory subunit 6B (26S proteasome AAA-ATPase subunit RPT3) (MB67-interacting protein) (MIP224) (Proteasome 26S subunit ATPase 4) (Tat-binding protein 7) (TBP-7) | Component of the 26S proteasome, a multiprotein complex involved in the ATP-dependent degradation of ubiquitinated proteins. This complex plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins, which could impair cellular functions, and by removing proteins whose functions are no longer required. Therefore, the proteasome participates in numerous cellular processes, including cell cycle progression, apoptosis, or DNA damage repair. PSMC4 belongs to the heterohexameric ring of AAA (ATPases associated with diverse cellular activities) proteins that unfolds ubiquitinated target proteins that are concurrently translocated into a proteolytic chamber and degraded into peptides. {ECO:0000269|PubMed:1317798, ECO:0000269|PubMed:8060531}. |
P48634 | PRRC2A | S1328 | ochoa | Protein PRRC2A (HLA-B-associated transcript 2) (Large proline-rich protein BAT2) (Proline-rich and coiled-coil-containing protein 2A) (Protein G2) | May play a role in the regulation of pre-mRNA splicing. {ECO:0000269|PubMed:14667819}. |
P48730 | CSNK1D | S328 | ochoa | Casein kinase I isoform delta (CKI-delta) (CKId) (EC 2.7.11.1) (Tau-protein kinase CSNK1D) (EC 2.7.11.26) | Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. In balance with PP1, determines the circadian period length through the regulation of the speed and rhythmicity of PER1 and PER2 phosphorylation. Controls PER1 and PER2 nuclear transport and degradation. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. Phosphorylates NEDD9/HEF1 (By similarity). EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate. {ECO:0000250|UniProtKB:Q9DC28, ECO:0000269|PubMed:10606744, ECO:0000269|PubMed:12270943, ECO:0000269|PubMed:14761950, ECO:0000269|PubMed:16027726, ECO:0000269|PubMed:17562708, ECO:0000269|PubMed:17962809, ECO:0000269|PubMed:19043076, ECO:0000269|PubMed:20041275, ECO:0000269|PubMed:20048001, ECO:0000269|PubMed:20407760, ECO:0000269|PubMed:20637175, ECO:0000269|PubMed:20696890, ECO:0000269|PubMed:20699359, ECO:0000269|PubMed:21084295, ECO:0000269|PubMed:21422228, ECO:0000269|PubMed:23636092}. |
P53814 | SMTN | S790 | ochoa | Smoothelin | Structural protein of the cytoskeleton. |
P55884 | EIF3B | S85 | ochoa | Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9) (Prt1 homolog) (hPrt1) (eIF-3-eta) (eIF3 p110) (eIF3 p116) | RNA-binding component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis (PubMed:17581632, PubMed:25849773, PubMed:27462815, PubMed:9388245). The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation (PubMed:17581632, PubMed:9388245). The eIF-3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression (PubMed:25849773). {ECO:0000255|HAMAP-Rule:MF_03001, ECO:0000269|PubMed:17581632, ECO:0000269|PubMed:25849773, ECO:0000269|PubMed:27462815, ECO:0000269|PubMed:9388245}.; FUNCTION: (Microbial infection) In case of FCV infection, plays a role in the ribosomal termination-reinitiation event leading to the translation of VP2 (PubMed:18056426). {ECO:0000269|PubMed:18056426}. |
P55884 | EIF3B | S125 | ochoa | Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9) (Prt1 homolog) (hPrt1) (eIF-3-eta) (eIF3 p110) (eIF3 p116) | RNA-binding component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis (PubMed:17581632, PubMed:25849773, PubMed:27462815, PubMed:9388245). The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation (PubMed:17581632, PubMed:9388245). The eIF-3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression (PubMed:25849773). {ECO:0000255|HAMAP-Rule:MF_03001, ECO:0000269|PubMed:17581632, ECO:0000269|PubMed:25849773, ECO:0000269|PubMed:27462815, ECO:0000269|PubMed:9388245}.; FUNCTION: (Microbial infection) In case of FCV infection, plays a role in the ribosomal termination-reinitiation event leading to the translation of VP2 (PubMed:18056426). {ECO:0000269|PubMed:18056426}. |
P57075 | UBASH3A | S382 | ochoa | Ubiquitin-associated and SH3 domain-containing protein A (Cbl-interacting protein 4) (CLIP4) (Suppressor of T-cell receptor signaling 2) (STS-2) (T-cell ubiquitin ligand 1) (TULA-1) | Interferes with CBL-mediated down-regulation and degradation of receptor-type tyrosine kinases. Promotes accumulation of activated target receptors, such as T-cell receptors, EGFR and PDGFRB, on the cell surface. Exhibits negligible protein tyrosine phosphatase activity at neutral pH. May act as a dominant-negative regulator of UBASH3B-dependent dephosphorylation. May inhibit dynamin-dependent endocytic pathways by functionally sequestering dynamin via its SH3 domain. {ECO:0000269|PubMed:15159412, ECO:0000269|PubMed:17382318, ECO:0000269|PubMed:18189269}. |
P78367 | NKX3-2 | S73 | ochoa | Homeobox protein Nkx-3.2 (Bagpipe homeobox protein homolog 1) (Homeobox protein NK-3 homolog B) | Transcriptional repressor that acts as a negative regulator of chondrocyte maturation. PLays a role in distal stomach development; required for proper antral-pyloric morphogenesis and development of antral-type epithelium. In concert with GSC, defines the structural components of the middle ear; required for tympanic ring and gonium development and in the regulation of the width of the malleus (By similarity). {ECO:0000250}. |
P82979 | SARNP | S118 | ochoa | SAP domain-containing ribonucleoprotein (Cytokine-induced protein of 29 kDa) (Nuclear protein Hcc-1) (Proliferation-associated cytokine-inducible protein CIP29) | Binds both single-stranded and double-stranded DNA with higher affinity for the single-stranded form. Specifically binds to scaffold/matrix attachment region DNA. Also binds single-stranded RNA. Enhances RNA unwinding activity of DDX39A. May participate in important transcriptional or translational control of cell growth, metabolism and carcinogenesis. Component of the TREX complex which is thought to couple mRNA transcription, processing and nuclear export, and specifically associates with spliced mRNA and not with unspliced pre-mRNA (PubMed:15338056, PubMed:17196963, PubMed:20844015). The TREX complex is recruited to spliced mRNAs by a transcription-independent mechanism, binds to mRNA upstream of the exon-junction complex (EJC) and is recruited in a splicing- and cap-dependent manner to a region near the 5' end of the mRNA where it functions in mRNA export to the cytoplasm via the TAP/NXF1 pathway (PubMed:15338056, PubMed:17196963, PubMed:20844015). Associates with DDX39B, which facilitates RNA binding of DDX39B and likely plays a role in mRNA export (PubMed:37578863). {ECO:0000269|PubMed:15338056, ECO:0000269|PubMed:17196963, ECO:0000269|PubMed:20844015, ECO:0000269|PubMed:37578863}. |
P83369 | LSM11 | S21 | ochoa | U7 snRNA-associated Sm-like protein LSm11 | Component of the U7 snRNP complex that is involved in the histone 3'-end pre-mRNA processing (PubMed:11574479, PubMed:16914750, PubMed:33230297). Increases U7 snRNA levels but not histone 3'-end pre-mRNA processing activity, when overexpressed (PubMed:11574479, PubMed:16914750). Required for cell cycle progression from G1 to S phases (By similarity). Binds specifically to the Sm-binding site of U7 snRNA (PubMed:11574479, PubMed:16914750). {ECO:0000250|UniProtKB:Q8BUV6, ECO:0000269|PubMed:11574479, ECO:0000269|PubMed:16914750, ECO:0000269|PubMed:33230297}. |
Q01826 | SATB1 | S465 | ochoa | DNA-binding protein SATB1 (Special AT-rich sequence-binding protein 1) | Crucial silencing factor contributing to the initiation of X inactivation mediated by Xist RNA that occurs during embryogenesis and in lymphoma (By similarity). Binds to DNA at special AT-rich sequences, the consensus SATB1-binding sequence (CSBS), at nuclear matrix- or scaffold-associated regions. Thought to recognize the sugar-phosphate structure of double-stranded DNA. Transcriptional repressor controlling nuclear and viral gene expression in a phosphorylated and acetylated status-dependent manner, by binding to matrix attachment regions (MARs) of DNA and inducing a local chromatin-loop remodeling. Acts as a docking site for several chromatin remodeling enzymes (e.g. PML at the MHC-I locus) and also by recruiting corepressors (HDACs) or coactivators (HATs) directly to promoters and enhancers. Modulates genes that are essential in the maturation of the immune T-cell CD8SP from thymocytes. Required for the switching of fetal globin species, and beta- and gamma-globin genes regulation during erythroid differentiation. Plays a role in chromatin organization and nuclear architecture during apoptosis. Interacts with the unique region (UR) of cytomegalovirus (CMV). Alu-like motifs and SATB1-binding sites provide a unique chromatin context which seems preferentially targeted by the HIV-1 integration machinery. Moreover, HIV-1 Tat may overcome SATB1-mediated repression of IL2 and IL2RA (interleukin) in T-cells by binding to the same domain than HDAC1. Delineates specific epigenetic modifications at target gene loci, directly up-regulating metastasis-associated genes while down-regulating tumor-suppressor genes. Reprograms chromatin organization and the transcription profiles of breast tumors to promote growth and metastasis. Promotes neuronal differentiation of neural stem/progenitor cells in the adult subventricular zone, possibly by positively regulating the expression of NEUROD1 (By similarity). {ECO:0000250|UniProtKB:Q60611, ECO:0000269|PubMed:10595394, ECO:0000269|PubMed:11463840, ECO:0000269|PubMed:12374985, ECO:0000269|PubMed:12692553, ECO:0000269|PubMed:1505028, ECO:0000269|PubMed:15618465, ECO:0000269|PubMed:15713622, ECO:0000269|PubMed:16377216, ECO:0000269|PubMed:16630892, ECO:0000269|PubMed:17173041, ECO:0000269|PubMed:17376900, ECO:0000269|PubMed:18337816, ECO:0000269|PubMed:19103759, ECO:0000269|PubMed:19247486, ECO:0000269|PubMed:19332023, ECO:0000269|PubMed:19430959, ECO:0000269|PubMed:33513338, ECO:0000269|PubMed:9111059, ECO:0000269|PubMed:9548713}. |
Q04656 | ATP7A | S325 | ochoa | Copper-transporting ATPase 1 (EC 7.2.2.8) (Copper pump 1) (Menkes disease-associated protein) | ATP-driven copper (Cu(+)) ion pump that plays an important role in intracellular copper ion homeostasis (PubMed:10419525, PubMed:11092760, PubMed:28389643). Within a catalytic cycle, acquires Cu(+) ion from donor protein on the cytoplasmic side of the membrane and delivers it to acceptor protein on the lumenal side. The transfer of Cu(+) ion across the membrane is coupled to ATP hydrolysis and is associated with a transient phosphorylation that shifts the pump conformation from inward-facing to outward-facing state (PubMed:10419525, PubMed:19453293, PubMed:19917612, PubMed:28389643, PubMed:31283225). Under physiological conditions, at low cytosolic copper concentration, it is localized at the trans-Golgi network (TGN) where it transfers Cu(+) ions to cuproenzymes of the secretory pathway (PubMed:11092760, PubMed:28389643). Upon elevated cytosolic copper concentrations, it relocalizes to the plasma membrane where it is responsible for the export of excess Cu(+) ions (PubMed:10419525, PubMed:28389643). May play a dual role in neuron function and survival by regulating cooper efflux and neuronal transmission at the synapse as well as by supplying Cu(+) ions to enzymes such as PAM, TYR and SOD3 (By similarity) (PubMed:28389643). In the melanosomes of pigmented cells, provides copper cofactor to TYR to form an active TYR holoenzyme for melanin biosynthesis (By similarity). {ECO:0000250|UniProtKB:Q64430, ECO:0000269|PubMed:10419525, ECO:0000269|PubMed:11092760, ECO:0000269|PubMed:19453293, ECO:0000269|PubMed:19917612, ECO:0000269|PubMed:28389643, ECO:0000269|PubMed:31283225}. |
Q13233 | MAP3K1 | S242 | ochoa | Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) (EC 2.3.2.27) | Component of a protein kinase signal transduction cascade (PubMed:9808624). Activates the ERK and JNK kinase pathways by phosphorylation of MAP2K1 and MAP2K4 (PubMed:9808624). May phosphorylate the MAPK8/JNK1 kinase (PubMed:17761173). Activates CHUK and IKBKB, the central protein kinases of the NF-kappa-B pathway (PubMed:9808624). {ECO:0000269|PubMed:17761173, ECO:0000269|PubMed:9808624}. |
Q13428 | TCOF1 | S801 | ochoa | Treacle protein (Treacher Collins syndrome protein) | Nucleolar protein that acts as a regulator of RNA polymerase I by connecting RNA polymerase I with enzymes responsible for ribosomal processing and modification (PubMed:12777385, PubMed:26399832). Required for neural crest specification: following monoubiquitination by the BCR(KBTBD8) complex, associates with NOLC1 and acts as a platform to connect RNA polymerase I with enzymes responsible for ribosomal processing and modification, leading to remodel the translational program of differentiating cells in favor of neural crest specification (PubMed:26399832). {ECO:0000269|PubMed:12777385, ECO:0000269|PubMed:26399832}. |
Q13439 | GOLGA4 | S27 | ochoa | Golgin subfamily A member 4 (256 kDa golgin) (Golgin-245) (Protein 72.1) (Trans-Golgi p230) | Involved in vesicular trafficking at the Golgi apparatus level. May play a role in delivery of transport vesicles containing GPI-linked proteins from the trans-Golgi network through its interaction with MACF1. Involved in endosome-to-Golgi trafficking (PubMed:29084197). {ECO:0000269|PubMed:15265687, ECO:0000269|PubMed:29084197}. |
Q13501 | SQSTM1 | S233 | ochoa | Sequestosome-1 (EBI3-associated protein of 60 kDa) (EBIAP) (p60) (Phosphotyrosine-independent ligand for the Lck SH2 domain of 62 kDa) (Ubiquitin-binding protein p62) (p62) | Molecular adapter required for selective macroautophagy (aggrephagy) by acting as a bridge between polyubiquitinated proteins and autophagosomes (PubMed:15340068, PubMed:15953362, PubMed:16286508, PubMed:17580304, PubMed:20168092, PubMed:22017874, PubMed:22622177, PubMed:24128730, PubMed:28404643, PubMed:29343546, PubMed:29507397, PubMed:31857589, PubMed:33509017, PubMed:34471133, PubMed:34893540, PubMed:35831301, PubMed:37306101, PubMed:37802024). Promotes the recruitment of ubiquitinated cargo proteins to autophagosomes via multiple domains that bridge proteins and organelles in different steps (PubMed:16286508, PubMed:20168092, PubMed:22622177, PubMed:24128730, PubMed:28404643, PubMed:29343546, PubMed:29507397, PubMed:34893540, PubMed:37802024). SQSTM1 first mediates the assembly and removal of ubiquitinated proteins by undergoing liquid-liquid phase separation upon binding to ubiquitinated proteins via its UBA domain, leading to the formation of insoluble cytoplasmic inclusions, known as p62 bodies (PubMed:15911346, PubMed:20168092, PubMed:22017874, PubMed:24128730, PubMed:29343546, PubMed:29507397, PubMed:31857589, PubMed:37802024). SQSTM1 then interacts with ATG8 family proteins on autophagosomes via its LIR motif, leading to p62 body recruitment to autophagosomes, followed by autophagic clearance of ubiquitinated proteins (PubMed:16286508, PubMed:17580304, PubMed:20168092, PubMed:22622177, PubMed:24128730, PubMed:28404643, PubMed:37802024). SQSTM1 is itself degraded along with its ubiquitinated cargos (PubMed:16286508, PubMed:17580304, PubMed:37802024). Also required to recruit ubiquitinated proteins to PML bodies in the nucleus (PubMed:20168092). Also involved in autophagy of peroxisomes (pexophagy) in response to reactive oxygen species (ROS) by acting as a bridge between ubiquitinated PEX5 receptor and autophagosomes (PubMed:26344566). Acts as an activator of the NFE2L2/NRF2 pathway via interaction with KEAP1: interaction inactivates the BCR(KEAP1) complex by sequestering the complex in inclusion bodies, promoting nuclear accumulation of NFE2L2/NRF2 and subsequent expression of cytoprotective genes (PubMed:20452972, PubMed:28380357, PubMed:33393215, PubMed:37306101). Promotes relocalization of 'Lys-63'-linked ubiquitinated STING1 to autophagosomes (PubMed:29496741). Involved in endosome organization by retaining vesicles in the perinuclear cloud: following ubiquitination by RNF26, attracts specific vesicle-associated adapters, forming a molecular bridge that restrains cognate vesicles in the perinuclear region and organizes the endosomal pathway for efficient cargo transport (PubMed:27368102, PubMed:33472082). Sequesters tensin TNS2 into cytoplasmic puncta, promoting TNS2 ubiquitination and proteasomal degradation (PubMed:25101860). May regulate the activation of NFKB1 by TNF-alpha, nerve growth factor (NGF) and interleukin-1 (PubMed:10356400, PubMed:10747026, PubMed:11244088, PubMed:12471037, PubMed:16079148, PubMed:19931284). May play a role in titin/TTN downstream signaling in muscle cells (PubMed:15802564). Adapter that mediates the interaction between TRAF6 and CYLD (By similarity). {ECO:0000250|UniProtKB:Q64337, ECO:0000269|PubMed:10356400, ECO:0000269|PubMed:10747026, ECO:0000269|PubMed:11244088, ECO:0000269|PubMed:12471037, ECO:0000269|PubMed:15340068, ECO:0000269|PubMed:15802564, ECO:0000269|PubMed:15911346, ECO:0000269|PubMed:15953362, ECO:0000269|PubMed:16079148, ECO:0000269|PubMed:16286508, ECO:0000269|PubMed:17580304, ECO:0000269|PubMed:19931284, ECO:0000269|PubMed:20168092, ECO:0000269|PubMed:20452972, ECO:0000269|PubMed:22017874, ECO:0000269|PubMed:22622177, ECO:0000269|PubMed:24128730, ECO:0000269|PubMed:25101860, ECO:0000269|PubMed:26344566, ECO:0000269|PubMed:27368102, ECO:0000269|PubMed:28380357, ECO:0000269|PubMed:28404643, ECO:0000269|PubMed:29343546, ECO:0000269|PubMed:29496741, ECO:0000269|PubMed:29507397, ECO:0000269|PubMed:31857589, ECO:0000269|PubMed:33393215, ECO:0000269|PubMed:33472082, ECO:0000269|PubMed:33509017, ECO:0000269|PubMed:34471133, ECO:0000269|PubMed:34893540, ECO:0000269|PubMed:35831301, ECO:0000269|PubMed:37306101, ECO:0000269|PubMed:37802024}. |
Q14004 | CDK13 | S867 | ochoa | Cyclin-dependent kinase 13 (EC 2.7.11.22) (EC 2.7.11.23) (CDC2-related protein kinase 5) (Cell division cycle 2-like protein kinase 5) (Cell division protein kinase 13) (hCDK13) (Cholinesterase-related cell division controller) | Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, probably by phosphorylating SRSF1/SF2. Required during hematopoiesis. In case of infection by HIV-1 virus, interacts with HIV-1 Tat protein acetylated at 'Lys-50' and 'Lys-51', thereby increasing HIV-1 mRNA splicing and promoting the production of the doubly spliced HIV-1 protein Nef. {ECO:0000269|PubMed:16721827, ECO:0000269|PubMed:1731328, ECO:0000269|PubMed:18480452, ECO:0000269|PubMed:20952539}. |
Q15149 | PLEC | S2749 | ochoa | Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1) | Interlinks intermediate filaments with microtubules and microfilaments and anchors intermediate filaments to desmosomes or hemidesmosomes. Could also bind muscle proteins such as actin to membrane complexes in muscle. May be involved not only in the filaments network, but also in the regulation of their dynamics. Structural component of muscle. Isoform 9 plays a major role in the maintenance of myofiber integrity. {ECO:0000269|PubMed:12482924, ECO:0000269|PubMed:21109228}. |
Q15569 | TESK1 | S603 | ochoa | Dual specificity testis-specific protein kinase 1 (EC 2.7.12.1) (Testicular protein kinase 1) | Dual specificity protein kinase activity catalyzing autophosphorylation and phosphorylation of exogenous substrates on both serine/threonine and tyrosine residues (By similarity). Regulates the cellular cytoskeleton by enhancing actin stress fiber formation via phosphorylation of cofilin and by preventing microtubule breakdown via inhibition of TAOK1/MARKK kinase activity (By similarity). Inhibits podocyte motility via regulation of actin cytoskeletal dynamics and phosphorylation of CFL1 (By similarity). Positively regulates integrin-mediated cell spreading, via phosphorylation of cofilin (PubMed:15584898). Suppresses ciliogenesis via multiple pathways; phosphorylation of CFL1, suppression of ciliary vesicle directional trafficking to the ciliary base, and by facilitating YAP1 nuclear localization where it acts as a transcriptional corepressor of the TEAD4 target genes AURKA and PLK1 (PubMed:25849865). Probably plays a central role at and after the meiotic phase of spermatogenesis (By similarity). {ECO:0000250|UniProtKB:O70146, ECO:0000250|UniProtKB:Q63572, ECO:0000269|PubMed:15584898, ECO:0000269|PubMed:25849865}. |
Q16825 | PTPN21 | S484 | ochoa | Tyrosine-protein phosphatase non-receptor type 21 (EC 3.1.3.48) (Protein-tyrosine phosphatase D1) | None |
Q4KMQ1 | TPRN | S418 | ochoa | Taperin | Essential for hearing (By similarity). Required for maintenance of stereocilia on both inner and outer hair cells (By similarity). Necessary for the integrity of the stereociliary rootlet (By similarity). May act as an actin cytoskeleton regulator involved in the regulation of actin dynamics at the pointed end in hair cells (By similarity). Forms rings at the base of stereocilia and binds actin filaments in the stereocilia which may stabilize the stereocilia (By similarity). Acts as a strong inhibitor of PPP1CA phosphatase activity (PubMed:23213405). Recruited to sites of DNA damage and may play a role in DNA damage repair (PubMed:23213405). {ECO:0000250|UniProtKB:A2AI08, ECO:0000269|PubMed:23213405}. |
Q5QJE6 | DNTTIP2 | S20 | ochoa | Deoxynucleotidyltransferase terminal-interacting protein 2 (Estrogen receptor-binding protein) (LPTS-interacting protein 2) (LPTS-RP2) (Terminal deoxynucleotidyltransferase-interacting factor 2) (TdIF2) (TdT-interacting factor 2) | Regulates the transcriptional activity of DNTT and ESR1. May function as a chromatin remodeling protein (PubMed:12786946, PubMed:15047147). Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and work in concert to generate RNA folding, modifications, rearrangements and cleavage as well as targeted degradation of pre-ribosomal RNA by the RNA exosome (PubMed:34516797). {ECO:0000269|PubMed:12786946, ECO:0000269|PubMed:15047147, ECO:0000269|PubMed:34516797}. |
Q5VST9 | OBSCN | S6942 | ochoa | Obscurin (EC 2.7.11.1) (Obscurin-RhoGEF) (Obscurin-myosin light chain kinase) (Obscurin-MLCK) | Structural component of striated muscles which plays a role in myofibrillogenesis. Probably involved in the assembly of myosin into sarcomeric A bands in striated muscle (PubMed:11448995, PubMed:16205939). Has serine/threonine protein kinase activity and phosphorylates N-cadherin CDH2 and sodium/potassium-transporting ATPase subunit ATP1B1 (By similarity). Binds (via the PH domain) strongly to phosphatidylinositol 3,4-bisphosphate (PtdIns(3,4)P2) and phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2), and to a lesser extent to phosphatidylinositol 3-phosphate (PtdIns(3)P), phosphatidylinositol 4-phosphate (PtdIns(4)P), phosphatidylinositol 5-phosphate (PtdIns(5)P) and phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3) (PubMed:28826662). {ECO:0000250|UniProtKB:A2AAJ9, ECO:0000269|PubMed:11448995, ECO:0000269|PubMed:16205939, ECO:0000269|PubMed:28826662}. |
Q5VV41 | ARHGEF16 | S107 | ochoa | Rho guanine nucleotide exchange factor 16 (Ephexin-4) | Guanyl-nucleotide exchange factor of the RHOG GTPase stimulating the exchange of RHOG-associated GDP for GTP. May play a role in chemotactic cell migration by mediating the activation of RAC1 by EPHA2. May also activate CDC42 and mediate activation of CDC42 by the viral protein HPV16 E6. {ECO:0000269|PubMed:20679435}. |
Q6NZI2 | CAVIN1 | S40 | ochoa | Caveolae-associated protein 1 (Cavin-1) (Polymerase I and transcript release factor) | Plays an important role in caveolae formation and organization. Essential for the formation of caveolae in all tissues (PubMed:18056712, PubMed:18191225, PubMed:19726876). Core component of the CAVIN complex which is essential for recruitment of the complex to the caveolae in presence of calveolin-1 (CAV1). Essential for normal oligomerization of CAV1. Promotes ribosomal transcriptional activity in response to metabolic challenges in the adipocytes and plays an important role in the formation of the ribosomal transcriptional loop. Dissociates transcription complexes paused by DNA-bound TTF1, thereby releasing both RNA polymerase I and pre-RNA from the template (By similarity) (PubMed:18056712, PubMed:18191225, PubMed:19726876). The caveolae biogenesis pathway is required for the secretion of proteins such as GASK1A (By similarity). {ECO:0000250|UniProtKB:O54724, ECO:0000269|PubMed:18056712, ECO:0000269|PubMed:18191225, ECO:0000269|PubMed:19726876}. |
Q6P996 | PDXDC1 | S669 | ochoa | Pyridoxal-dependent decarboxylase domain-containing protein 1 (EC 4.1.1.-) | None |
Q6ZUT6 | CCDC9B | S209 | ochoa | Coiled-coil domain-containing protein 9B | None |
Q7Z434 | MAVS | S275 | ochoa | Mitochondrial antiviral-signaling protein (MAVS) (CARD adapter inducing interferon beta) (Cardif) (Interferon beta promoter stimulator protein 1) (IPS-1) (Putative NF-kappa-B-activating protein 031N) (Virus-induced-signaling adapter) (VISA) | Adapter required for innate immune defense against viruses (PubMed:16125763, PubMed:16127453, PubMed:16153868, PubMed:16177806, PubMed:19631370, PubMed:20127681, PubMed:20451243, PubMed:21170385, PubMed:23087404, PubMed:27992402, PubMed:33139700, PubMed:37582970). Acts downstream of DHX33, RIGI and IFIH1/MDA5, which detect intracellular dsRNA produced during viral replication, to coordinate pathways leading to the activation of NF-kappa-B, IRF3 and IRF7, and to the subsequent induction of antiviral cytokines such as IFNB and RANTES (CCL5) (PubMed:16125763, PubMed:16127453, PubMed:16153868, PubMed:16177806, PubMed:19631370, PubMed:20127681, PubMed:20451243, PubMed:20628368, PubMed:21170385, PubMed:23087404, PubMed:25636800, PubMed:27736772, PubMed:33110251). Peroxisomal and mitochondrial MAVS act sequentially to create an antiviral cellular state (PubMed:20451243). Upon viral infection, peroxisomal MAVS induces the rapid interferon-independent expression of defense factors that provide short-term protection, whereas mitochondrial MAVS activates an interferon-dependent signaling pathway with delayed kinetics, which amplifies and stabilizes the antiviral response (PubMed:20451243). May activate the same pathways following detection of extracellular dsRNA by TLR3 (PubMed:16153868). May protect cells from apoptosis (PubMed:16125763). Involved in NLRP3 inflammasome activation by mediating NLRP3 recruitment to mitochondria (PubMed:23582325). {ECO:0000269|PubMed:16125763, ECO:0000269|PubMed:16127453, ECO:0000269|PubMed:16153868, ECO:0000269|PubMed:16177806, ECO:0000269|PubMed:19631370, ECO:0000269|PubMed:20127681, ECO:0000269|PubMed:20451243, ECO:0000269|PubMed:20628368, ECO:0000269|PubMed:21170385, ECO:0000269|PubMed:23087404, ECO:0000269|PubMed:23582325, ECO:0000269|PubMed:25636800, ECO:0000269|PubMed:27736772, ECO:0000269|PubMed:27992402, ECO:0000269|PubMed:33110251, ECO:0000269|PubMed:33139700, ECO:0000269|PubMed:37582970}. |
Q7Z5L9 | IRF2BP2 | S131 | ochoa | Interferon regulatory factor 2-binding protein 2 (IRF-2-binding protein 2) (IRF-2BP2) | Acts as a transcriptional corepressor in a IRF2-dependent manner; this repression is not mediated by histone deacetylase activities (PubMed:12799427). Represses the NFAT1-dependent transactivation of NFAT-responsive promoters (PubMed:21576369). Acts as a coactivator of VEGFA expression in cardiac and skeletal muscles (PubMed:20702774). Plays a role in immature B-cell differentiation (PubMed:27016798). {ECO:0000269|PubMed:12799427, ECO:0000269|PubMed:20702774, ECO:0000269|PubMed:21576369, ECO:0000269|PubMed:27016798}. |
Q7Z7C8 | TAF8 | S278 | ochoa | Transcription initiation factor TFIID subunit 8 (Protein taube nuss) (TBP-associated factor 43 kDa) (TBP-associated factor 8) (Transcription initiation factor TFIID 43 kDa subunit) (TAFII-43) (TAFII43) (hTAFII43) | The TFIID basal transcription factor complex plays a major role in the initiation of RNA polymerase II (Pol II)-dependent transcription (PubMed:33795473). TFIID recognizes and binds promoters with or without a TATA box via its subunit TBP, a TATA-box-binding protein, and promotes assembly of the pre-initiation complex (PIC) (PubMed:33795473). The TFIID complex consists of TBP and TBP-associated factors (TAFs), including TAF1, TAF2, TAF3, TAF4, TAF5, TAF6, TAF7, TAF8, TAF9, TAF10, TAF11, TAF12 and TAF13 (PubMed:33795473). The TFIID complex structure can be divided into 3 modules TFIID-A, TFIID-B, and TFIID-C (PubMed:33795473). TAF8 is involved in forming the TFIID-B module, together with TAF5 (PubMed:33795473). Mediates both basal and activator-dependent transcription (PubMed:14580349). Plays a role in the differentiation of preadipocyte fibroblasts to adipocytes, however, does not seem to play a role in differentiation of myoblasts (PubMed:14580349). Required for the integration of TAF10 in the TAF complex (PubMed:14580349). May be important for survival of cells of the inner cell mass which constitute the pluripotent cell population of the early embryo (By similarity). {ECO:0000250|UniProtKB:Q9EQH4, ECO:0000269|PubMed:14580349, ECO:0000269|PubMed:33795473}. |
Q86YP4 | GATAD2A | S326 | ochoa | Transcriptional repressor p66-alpha (Hp66alpha) (GATA zinc finger domain-containing protein 2A) | Transcriptional repressor (PubMed:12183469, PubMed:16415179). Acts as a component of the histone deacetylase NuRD complex which participates in the remodeling of chromatin (PubMed:16428440, PubMed:28977666). Enhances MBD2-mediated repression (PubMed:12183469, PubMed:16415179). Efficient repression requires the presence of GATAD2B (PubMed:16415179). {ECO:0000269|PubMed:12183469, ECO:0000269|PubMed:16415179, ECO:0000269|PubMed:16428440, ECO:0000269|PubMed:28977666}. |
Q8N201 | INTS1 | S104 | ochoa | Integrator complex subunit 1 (Int1) | Component of the integrator complex, a multiprotein complex that terminates RNA polymerase II (Pol II) transcription in the promoter-proximal region of genes (PubMed:25201415, PubMed:33243860, PubMed:38570683). The integrator complex provides a quality checkpoint during transcription elongation by driving premature transcription termination of transcripts that are unfavorably configured for transcriptional elongation: the complex terminates transcription by (1) catalyzing dephosphorylation of the C-terminal domain (CTD) of Pol II subunit POLR2A/RPB1 and SUPT5H/SPT5, (2) degrading the exiting nascent RNA transcript via endonuclease activity and (3) promoting the release of Pol II from bound DNA (PubMed:33243860). The integrator complex is also involved in terminating the synthesis of non-coding Pol II transcripts, such as enhancer RNAs (eRNAs), small nuclear RNAs (snRNAs), telomerase RNAs and long non-coding RNAs (lncRNAs) (PubMed:16239144, PubMed:26308897, PubMed:30737432). Within the integrator complex, INTS1 is involved in the post-termination step: INTS1 displaces INTS3 and the SOSS factors, allowing the integrator complex to return to the closed conformation, ready to bind to the paused elongation complex for another termination cycle (PubMed:38570683). Mediates recruitment of cytoplasmic dynein to the nuclear envelope, probably as component of the integrator complex (PubMed:23904267). {ECO:0000269|PubMed:16239144, ECO:0000269|PubMed:23904267, ECO:0000269|PubMed:25201415, ECO:0000269|PubMed:26308897, ECO:0000269|PubMed:30737432, ECO:0000269|PubMed:33243860, ECO:0000269|PubMed:38570683}. |
Q8N6S5 | ARL6IP6 | S65 | ochoa | ADP-ribosylation factor-like protein 6-interacting protein 6 (ARL-6-interacting protein 6) (Aip-6) (Phosphonoformate immuno-associated protein 1) | None |
Q8TD26 | CHD6 | S2674 | ochoa | Chromodomain-helicase-DNA-binding protein 6 (CHD-6) (EC 3.6.4.-) (ATP-dependent helicase CHD6) (Radiation-induced gene B protein) | ATP-dependent chromatin-remodeling factor (PubMed:17027977, PubMed:28533432). Regulates transcription by disrupting nucleosomes in a largely non-sliding manner which strongly increases the accessibility of chromatin; nucleosome disruption requires ATP (PubMed:28533432). Activates transcription of specific genes in response to oxidative stress through interaction with NFE2L2. {ECO:0000269|PubMed:16314513, ECO:0000269|PubMed:17027977, ECO:0000269|PubMed:28533432}.; FUNCTION: (Microbial infection) Acts as a transcriptional repressor of different viruses including influenza virus or papillomavirus. During influenza virus infection, the viral polymerase complex localizes CHD6 to inactive chromatin where it gets degraded in a proteasome independent-manner. {ECO:0000269|PubMed:20631145, ECO:0000269|PubMed:21899694, ECO:0000269|PubMed:23408615}. |
Q8TF72 | SHROOM3 | S1138 | ochoa | Protein Shroom3 (Shroom-related protein) (hShrmL) | Controls cell shape changes in the neuroepithelium during neural tube closure. Induces apical constriction in epithelial cells by promoting the apical accumulation of F-actin and myosin II, and probably by bundling stress fibers (By similarity). Induces apicobasal cell elongation by redistributing gamma-tubulin and directing the assembly of robust apicobasal microtubule arrays (By similarity). {ECO:0000250|UniProtKB:Q27IV2, ECO:0000250|UniProtKB:Q9QXN0}. |
Q8WVB6 | CHTF18 | S70 | ochoa | Chromosome transmission fidelity protein 18 homolog (hCTF18) (CHL12) | Chromosome cohesion factor involved in sister chromatid cohesion and fidelity of chromosome transmission. Component of one of the cell nuclear antigen loader complexes, CTF18-replication factor C (CTF18-RFC), which consists of CTF18, CTF8, DCC1, RFC2, RFC3, RFC4 and RFC5. The CTF18-RFC complex binds to single-stranded and primed DNAs and has weak ATPase activity that is stimulated by the presence of primed DNA, replication protein A (RPA) and by proliferating cell nuclear antigen (PCNA). The CTF18-RFC complex catalyzes the ATP-dependent loading of PCNA onto primed and gapped DNA. Interacts with and stimulates DNA polymerase POLH. During DNA repair synthesis, involved in loading DNA polymerase POLE at the sites of local damage (PubMed:20227374). {ECO:0000269|PubMed:12766176, ECO:0000269|PubMed:12930902, ECO:0000269|PubMed:17545166, ECO:0000269|PubMed:20227374}. |
Q96HC4 | PDLIM5 | S319 | ochoa | PDZ and LIM domain protein 5 (Enigma homolog) (Enigma-like PDZ and LIM domains protein) | May play an important role in the heart development by scaffolding PKC to the Z-disk region. May play a role in the regulation of cardiomyocyte expansion. Isoforms lacking the LIM domains may negatively modulate the scaffolding activity of isoform 1. Overexpression promotes the development of heart hypertrophy. Contributes to the regulation of dendritic spine morphogenesis in neurons. May be required to restrain postsynaptic growth of excitatory synapses. Isoform 1, but not isoform 2, expression favors spine thinning and elongation. {ECO:0000250|UniProtKB:Q62920}. |
Q96I24 | FUBP3 | S539 | ochoa | Far upstream element-binding protein 3 (FUSE-binding protein 3) | May interact with single-stranded DNA from the far-upstream element (FUSE). May activate gene expression. |
Q96JH8 | RADIL | S962 | ochoa | Ras-associating and dilute domain-containing protein | Downstream effector of Rap required for cell adhesion and migration of neural crest precursors during development. {ECO:0000269|PubMed:17704304}. |
Q96RK0 | CIC | S1294 | ochoa | Protein capicua homolog | Transcriptional repressor which plays a role in development of the central nervous system (CNS). In concert with ATXN1 and ATXN1L, involved in brain development. {ECO:0000250|UniProtKB:Q924A2}. |
Q96T23 | RSF1 | S515 | ochoa | Remodeling and spacing factor 1 (Rsf-1) (HBV pX-associated protein 8) (Hepatitis B virus X-associated protein) (p325 subunit of RSF chromatin-remodeling complex) | Regulatory subunit of the ATP-dependent RSF-1 and RSF-5 ISWI chromatin-remodeling complexes, which form ordered nucleosome arrays on chromatin and facilitate access to DNA during DNA-templated processes such as DNA replication, transcription, and repair (PubMed:12972596, PubMed:28801535). Binds to core histones together with SMARCA5, and is required for the assembly of regular nucleosome arrays by the RSF-5 ISWI chromatin-remodeling complex (PubMed:12972596). Directly stimulates the ATPase activity of SMARCA1 and SMARCA5 in the RSF-1 and RSF-5 ISWI chromatin-remodeling complexes, respectively (PubMed:28801535). The RSF-1 ISWI chromatin remodeling complex has a lower ATP hydrolysis rate than the RSF-5 ISWI chromatin-remodeling complex (PubMed:28801535). The complexes do not have the ability to slide mononucleosomes to the center of a DNA template (PubMed:28801535). Facilitates transcription of hepatitis B virus (HBV) genes by the pX transcription activator. In case of infection by HBV, together with pX, it represses TNF-alpha induced NF-kappa-B transcription activation. Represses transcription when artificially recruited to chromatin by fusion to a heterogeneous DNA binding domain (PubMed:11788598, PubMed:11944984). {ECO:0000269|PubMed:11788598, ECO:0000269|PubMed:11944984, ECO:0000269|PubMed:12972596, ECO:0000269|PubMed:28801535}. |
Q9BV73 | CEP250 | S2322 | ochoa | Centrosome-associated protein CEP250 (250 kDa centrosomal protein) (Cep250) (Centrosomal Nek2-associated protein 1) (C-Nap1) (Centrosomal protein 2) | Plays an important role in centrosome cohesion during interphase (PubMed:30404835, PubMed:36282799). Recruits CCDC102B to the proximal ends of centrioles (PubMed:30404835). Maintains centrosome cohesion by forming intercentriolar linkages (PubMed:36282799). Accumulates at the proximal end of each centriole, forming supramolecular assemblies with viscous material properties that promote organelle cohesion (PubMed:36282799). May be involved in ciliogenesis (PubMed:28005958). {ECO:0000269|PubMed:28005958, ECO:0000269|PubMed:30404835, ECO:0000269|PubMed:36282799}. |
Q9BYB0 | SHANK3 | S686 | ochoa | SH3 and multiple ankyrin repeat domains protein 3 (Shank3) (Proline-rich synapse-associated protein 2) (ProSAP2) | Major scaffold postsynaptic density protein which interacts with multiple proteins and complexes to orchestrate the dendritic spine and synapse formation, maturation and maintenance. Interconnects receptors of the postsynaptic membrane including NMDA-type and metabotropic glutamate receptors via complexes with GKAP/PSD-95 and HOMER, respectively, and the actin-based cytoskeleton. Plays a role in the structural and functional organization of the dendritic spine and synaptic junction through the interaction with Arp2/3 and WAVE1 complex as well as the promotion of the F-actin clusters. By way of this control of actin dynamics, participates in the regulation of developing neurons growth cone motility and the NMDA receptor-signaling. Also modulates GRIA1 exocytosis and GRM5/MGLUR5 expression and signaling to control the AMPA and metabotropic glutamate receptor-mediated synaptic transmission and plasticity. May be required at an early stage of synapse formation and be inhibited by IGF1 to promote synapse maturation. {ECO:0000269|PubMed:24132240}. |
Q9C073 | FAM117A | S305 | ochoa | Protein FAM117A (C/EBP-induced protein) | None |
Q9C0C2 | TNKS1BP1 | S369 | ochoa | 182 kDa tankyrase-1-binding protein | None |
Q9H211 | CDT1 | S380 | ochoa | DNA replication factor Cdt1 (Double parked homolog) (DUP) | Required for both DNA replication and mitosis (PubMed:11125146, PubMed:14993212, PubMed:21856198, PubMed:22581055, PubMed:26842564). DNA replication licensing factor, required for pre-replication complex assembly. Cooperates with CDC6 and the origin recognition complex (ORC) during G1 phase of the cell cycle to promote the loading of the mini-chromosome maintenance (MCM) complex onto DNA to generate pre-replication complexes (pre-RC) (PubMed:14672932). Required also for mitosis by promoting stable kinetochore-microtubule attachments (PubMed:22581055). Potential oncogene (By similarity). {ECO:0000250|UniProtKB:Q8R4E9, ECO:0000269|PubMed:11125146, ECO:0000269|PubMed:14672932, ECO:0000269|PubMed:14993212, ECO:0000269|PubMed:21856198, ECO:0000269|PubMed:22581055, ECO:0000269|PubMed:26842564}. |
Q9HCM7 | FBRSL1 | S141 | ochoa | Fibrosin-1-like protein (AUTS2-like protein) (HBV X-transactivated gene 9 protein) (HBV XAg-transactivated protein 9) | None |
Q9NR33 | POLE4 | S32 | ochoa | DNA polymerase epsilon subunit 4 (DNA polymerase II subunit 4) (DNA polymerase epsilon subunit p12) | Accessory component of the DNA polymerase epsilon complex (PubMed:10801849). Participates in DNA repair and in chromosomal DNA replication (By similarity). {ECO:0000250|UniProtKB:P27344, ECO:0000269|PubMed:10801849}. |
Q9NYV4 | CDK12 | S889 | ochoa | Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (hCDK12) | Cyclin-dependent kinase that phosphorylates the C-terminal domain (CTD) of the large subunit of RNA polymerase II (POLR2A), thereby acting as a key regulator of transcription elongation. Regulates the expression of genes involved in DNA repair and is required for the maintenance of genomic stability. Preferentially phosphorylates 'Ser-5' in CTD repeats that are already phosphorylated at 'Ser-7', but can also phosphorylate 'Ser-2'. Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogen inhibitors. {ECO:0000269|PubMed:11683387, ECO:0000269|PubMed:19651820, ECO:0000269|PubMed:20952539, ECO:0000269|PubMed:22012619, ECO:0000269|PubMed:24662513}. |
Q9P2G1 | ANKIB1 | S898 | ochoa | Ankyrin repeat and IBR domain-containing protein 1 (EC 2.3.2.31) | Might act as an E3 ubiquitin-protein ligase, or as part of E3 complex, which accepts ubiquitin from specific E2 ubiquitin-conjugating enzymes and then transfers it to substrates. {ECO:0000250}. |
Q9UBB6 | NCDN | S448 | ochoa | Neurochondrin | Probably involved in signal transduction in the nervous system, via increasing cell surface localization of GRM5/mGluR5 and positively regulating its signaling (PubMed:33711248). Required for the spatial learning process. Acts as a negative regulator of Ca(2+)-calmodulin-dependent protein kinase 2 (CaMK2) phosphorylation. May play a role in modulating melanin-concentrating hormone-mediated functions via its interaction with MCHR1 that interferes with G protein-coupled signal transduction. May be involved in bone metabolism. May also be involved in neurite outgrowth (Probable). {ECO:0000269|PubMed:16945926, ECO:0000269|PubMed:33711248, ECO:0000305|PubMed:33711248}. |
Q9UK61 | TASOR | S68 | ochoa | Protein TASOR (CTCL tumor antigen se89-1) (Retinoblastoma-associated protein RAP140) (Transgene activation suppressor protein) | Component of the HUSH complex, a multiprotein complex that mediates epigenetic repression (PubMed:26022416, PubMed:28581500). The HUSH complex is recruited to genomic loci rich in H3K9me3 and is required to maintain transcriptional silencing by promoting recruitment of SETDB1, a histone methyltransferase that mediates further deposition of H3K9me3, as well as MORC2 (PubMed:26022416, PubMed:28581500). Also represses L1 retrotransposons in collaboration with MORC2 and, probably, SETDB1, the silencing is dependent of repressive epigenetic modifications, such as H3K9me3 mark. Silencing events often occur within introns of transcriptionally active genes, and lead to the down-regulation of host gene expression (PubMed:29211708). The HUSH complex is also involved in the silencing of unintegrated retroviral DNA by being recruited by ZNF638: some part of the retroviral DNA formed immediately after infection remains unintegrated in the host genome and is transcriptionally repressed (PubMed:30487602). Plays a crucial role in early embryonic development (By similarity). Involved in the organization of spindle poles and spindle apparatus assembly during zygotic division (By similarity). Plays an important role in maintaining epiblast fitness or potency (By similarity). {ECO:0000250|UniProtKB:Q69ZR9, ECO:0000269|PubMed:26022416, ECO:0000269|PubMed:28581500, ECO:0000269|PubMed:29211708, ECO:0000269|PubMed:30487602}. |
Q9UKX2 | MYH2 | Y389 | ochoa | Myosin-2 (Myosin heavy chain 2) (Myosin heavy chain 2a) (MyHC-2a) (Myosin heavy chain IIa) (MyHC-IIa) (Myosin heavy chain, skeletal muscle, adult 2) | Myosins are actin-based motor molecules with ATPase activity essential for muscle contraction. {ECO:0000250|UniProtKB:P12883}. |
Q9Y2J2 | EPB41L3 | S55 | ochoa | Band 4.1-like protein 3 (4.1B) (Differentially expressed in adenocarcinoma of the lung protein 1) (DAL-1) (Erythrocyte membrane protein band 4.1-like 3) [Cleaved into: Band 4.1-like protein 3, N-terminally processed] | Tumor suppressor that inhibits cell proliferation and promotes apoptosis. Modulates the activity of protein arginine N-methyltransferases, including PRMT3 and PRMT5. {ECO:0000269|PubMed:15334060, ECO:0000269|PubMed:15737618, ECO:0000269|PubMed:16420693, ECO:0000269|PubMed:9892180}. |
Q9Y2U8 | LEMD3 | S351 | ochoa | Inner nuclear membrane protein Man1 (LEM domain-containing protein 3) | Can function as a specific repressor of TGF-beta, activin, and BMP signaling through its interaction with the R-SMAD proteins. Antagonizes TGF-beta-induced cell proliferation arrest. {ECO:0000269|PubMed:15601644, ECO:0000269|PubMed:15647271}. |
Q9Y3X0 | CCDC9 | S362 | ochoa | Coiled-coil domain-containing protein 9 | Probable component of the exon junction complex (EJC), a multiprotein complex that associates immediately upstream of the exon-exon junction on mRNAs and serves as a positional landmark for the intron exon structure of genes and directs post-transcriptional processes in the cytoplasm such as mRNA export, nonsense-mediated mRNA decay (NMD) or translation. {ECO:0000305|PubMed:33973408}. |
Q9Y6A5 | TACC3 | S250 | ochoa | Transforming acidic coiled-coil-containing protein 3 (ERIC-1) | Plays a role in the microtubule-dependent coupling of the nucleus and the centrosome. Involved in the processes that regulate centrosome-mediated interkinetic nuclear migration (INM) of neural progenitors (By similarity). Acts as a component of the TACC3/ch-TOG/clathrin complex proposed to contribute to stabilization of kinetochore fibers of the mitotic spindle by acting as inter-microtubule bridge. The TACC3/ch-TOG/clathrin complex is required for the maintenance of kinetochore fiber tension (PubMed:21297582, PubMed:23532825). May be involved in the control of cell growth and differentiation. May contribute to cancer (PubMed:14767476). {ECO:0000250|UniProtKB:Q9JJ11, ECO:0000269|PubMed:14767476, ECO:0000269|PubMed:21297582, ECO:0000269|PubMed:23532825}. |
P36578 | RPL4 | S66 | Sugiyama | Large ribosomal subunit protein uL4 (60S ribosomal protein L1) (60S ribosomal protein L4) | Component of the large ribosomal subunit. The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell. {ECO:0000269|PubMed:23636399, ECO:0000269|PubMed:32669547}. |
Q14152 | EIF3A | S513 | Sugiyama | Eukaryotic translation initiation factor 3 subunit A (eIF3a) (Eukaryotic translation initiation factor 3 subunit 10) (eIF-3-theta) (eIF3 p167) (eIF3 p180) (eIF3 p185) | RNA-binding component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis (PubMed:17581632, PubMed:25849773). The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation (PubMed:11169732, PubMed:17581632). The eIF-3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression (PubMed:25849773, PubMed:27462815). {ECO:0000255|HAMAP-Rule:MF_03000, ECO:0000269|PubMed:11169732, ECO:0000269|PubMed:17581632, ECO:0000269|PubMed:25849773, ECO:0000269|PubMed:27462815}.; FUNCTION: (Microbial infection) Essential for the initiation of translation on type-1 viral ribosomal entry sites (IRESs), like for HCV, PV, EV71 or BEV translation (PubMed:23766293, PubMed:24357634). {ECO:0000269|PubMed:23766293, ECO:0000269|PubMed:24357634}.; FUNCTION: (Microbial infection) In case of FCV infection, plays a role in the ribosomal termination-reinitiation event leading to the translation of VP2 (PubMed:18056426). {ECO:0000269|PubMed:18056426}. |
P78316 | NOP14 | S29 | Sugiyama | Nucleolar protein 14 (Nucleolar complex protein 14) | Involved in nucleolar processing of pre-18S ribosomal RNA. Has a role in the nuclear export of 40S pre-ribosomal subunit to the cytoplasm (By similarity). {ECO:0000250}. |
P04075 | ALDOA | Y174 | Sugiyama | Fructose-bisphosphate aldolase A (EC 4.1.2.13) (Lung cancer antigen NY-LU-1) (Muscle-type aldolase) | Catalyzes the reversible conversion of beta-D-fructose 1,6-bisphosphate (FBP) into two triose phosphate and plays a key role in glycolysis and gluconeogenesis (PubMed:14766013). In addition, may also function as scaffolding protein (By similarity). {ECO:0000250, ECO:0000269|PubMed:14766013}. |
P09972 | ALDOC | Y174 | Sugiyama | Fructose-bisphosphate aldolase C (EC 4.1.2.13) (Brain-type aldolase) | None |
P49419 | ALDH7A1 | T91 | Sugiyama | Alpha-aminoadipic semialdehyde dehydrogenase (Alpha-AASA dehydrogenase) (EC 1.2.1.31) (Aldehyde dehydrogenase family 7 member A1) (EC 1.2.1.3) (Antiquitin-1) (Betaine aldehyde dehydrogenase) (EC 1.2.1.8) (Delta1-piperideine-6-carboxylate dehydrogenase) (P6c dehydrogenase) | Multifunctional enzyme mediating important protective effects. Metabolizes betaine aldehyde to betaine, an important cellular osmolyte and methyl donor. Protects cells from oxidative stress by metabolizing a number of lipid peroxidation-derived aldehydes. Involved in lysine catabolism. {ECO:0000269|PubMed:16491085, ECO:0000269|PubMed:20207735, ECO:0000269|PubMed:21338592}. |
O00273 | DFFA | S302 | Sugiyama | DNA fragmentation factor subunit alpha (DNA fragmentation factor 45 kDa subunit) (DFF-45) (Inhibitor of CAD) (ICAD) | Inhibitor of the caspase-activated DNase (DFF40). |
Q86TU7 | SETD3 | S505 | Sugiyama | Actin-histidine N-methyltransferase (EC 2.1.1.85) (Protein-L-histidine N-tele-methyltransferase) (SET domain-containing protein 3) (hSETD3) | Protein-histidine N-methyltransferase that specifically mediates 3-methylhistidine (tele-methylhistidine) methylation of actin at 'His-73' (PubMed:30526847, PubMed:30626964, PubMed:30785395, PubMed:31388018, PubMed:31993215). Histidine methylation of actin is required for smooth muscle contraction of the laboring uterus during delivery (PubMed:30626964). Does not have protein-lysine N-methyltransferase activity and probably only catalyzes histidine methylation of actin (PubMed:30626964, PubMed:30785395, PubMed:31388018). {ECO:0000269|PubMed:30526847, ECO:0000269|PubMed:30626964, ECO:0000269|PubMed:30785395, ECO:0000269|PubMed:31388018, ECO:0000269|PubMed:31993215}. |
Q14204 | DYNC1H1 | S3920 | Sugiyama | Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic) | Cytoplasmic dynein 1 acts as a motor for the intracellular retrograde motility of vesicles and organelles along microtubules. Dynein has ATPase activity; the force-producing power stroke is thought to occur on release of ADP. Plays a role in mitotic spindle assembly and metaphase plate congression (PubMed:27462074). {ECO:0000269|PubMed:27462074}. |
Q96J92 | WNK4 | S122 | Sugiyama | Serine/threonine-protein kinase WNK4 (EC 2.7.11.1) (Protein kinase lysine-deficient 4) (Protein kinase with no lysine 4) | Serine/threonine-protein kinase component of the WNK4-SPAK/OSR1 kinase cascade, which acts as a key regulator of ion transport in the distal nephron and blood pressure (By similarity). The WNK4-SPAK/OSR1 kinase cascade is composed of WNK4, which mediates phosphorylation and activation of downstream kinases OXSR1/OSR1 and STK39/SPAK (PubMed:16832045). Following activation, OXSR1/OSR1 and STK39/SPAK catalyze phosphorylation of ion cotransporters, such as SLC12A1/NKCC2, SLC12A2/NKCC1, SLC12A3/NCC, SLC12A5/KCC2 or SLC12A6/KCC3, regulating their activity (PubMed:16832045, PubMed:22989884). Acts as a molecular switch that regulates the balance between renal salt reabsorption and K(+) secretion by modulating the activities of renal transporters and channels, including the Na-Cl cotransporter SLC12A3/NCC and the K(+) channel, KCNJ1/ROMK (By similarity). Regulates NaCl reabsorption in the distal nephron by activating the thiazide-sensitive Na-Cl cotransporter SLC12A3/NCC in distal convoluted tubule cells of kidney: activates SLC12A3/NCC in a OXSR1/OSR1- and STK39/SPAK-dependent process (By similarity). Also acts as a scaffold protein independently of its protein kinase activity: negatively regulates cell membrane localization of various transporters and channels (CFTR, KCNJ1/ROMK, SLC4A4, SLC26A9 and TRPV4) by clathrin-dependent endocytosis (By similarity). Also inhibits the activity of the epithelial Na(+) channel (ENaC) SCNN1A, SCNN1B, SCNN1D in a inase-independent mechanism (By similarity). May also phosphorylate NEDD4L (PubMed:20525693). {ECO:0000250|UniProtKB:Q80UE6, ECO:0000269|PubMed:16832045, ECO:0000269|PubMed:20525693, ECO:0000269|PubMed:22989884}. |
Q9UM73 | ALK | S1427 | Sugiyama | ALK tyrosine kinase receptor (EC 2.7.10.1) (Anaplastic lymphoma kinase) (CD antigen CD246) | Neuronal receptor tyrosine kinase that is essentially and transiently expressed in specific regions of the central and peripheral nervous systems and plays an important role in the genesis and differentiation of the nervous system (PubMed:11121404, PubMed:11387242, PubMed:16317043, PubMed:17274988, PubMed:30061385, PubMed:34646012, PubMed:34819673). Also acts as a key thinness protein involved in the resistance to weight gain: in hypothalamic neurons, controls energy expenditure acting as a negative regulator of white adipose tissue lipolysis and sympathetic tone to fine-tune energy homeostasis (By similarity). Following activation by ALKAL2 ligand at the cell surface, transduces an extracellular signal into an intracellular response (PubMed:30061385, PubMed:33411331, PubMed:34646012, PubMed:34819673). In contrast, ALKAL1 is not a potent physiological ligand for ALK (PubMed:34646012). Ligand-binding to the extracellular domain induces tyrosine kinase activation, leading to activation of the mitogen-activated protein kinase (MAPK) pathway (PubMed:34819673). Phosphorylates almost exclusively at the first tyrosine of the Y-x-x-x-Y-Y motif (PubMed:15226403, PubMed:16878150). Induces tyrosine phosphorylation of CBL, FRS2, IRS1 and SHC1, as well as of the MAP kinases MAPK1/ERK2 and MAPK3/ERK1 (PubMed:15226403, PubMed:16878150). ALK activation may also be regulated by pleiotrophin (PTN) and midkine (MDK) (PubMed:11278720, PubMed:11809760, PubMed:12107166, PubMed:12122009). PTN-binding induces MAPK pathway activation, which is important for the anti-apoptotic signaling of PTN and regulation of cell proliferation (PubMed:11278720, PubMed:11809760, PubMed:12107166). MDK-binding induces phosphorylation of the ALK target insulin receptor substrate (IRS1), activates mitogen-activated protein kinases (MAPKs) and PI3-kinase, resulting also in cell proliferation induction (PubMed:12122009). Drives NF-kappa-B activation, probably through IRS1 and the activation of the AKT serine/threonine kinase (PubMed:15226403, PubMed:16878150). Recruitment of IRS1 to activated ALK and the activation of NF-kappa-B are essential for the autocrine growth and survival signaling of MDK (PubMed:15226403, PubMed:16878150). {ECO:0000250|UniProtKB:P97793, ECO:0000269|PubMed:11121404, ECO:0000269|PubMed:11278720, ECO:0000269|PubMed:11387242, ECO:0000269|PubMed:11809760, ECO:0000269|PubMed:12107166, ECO:0000269|PubMed:12122009, ECO:0000269|PubMed:15226403, ECO:0000269|PubMed:16317043, ECO:0000269|PubMed:16878150, ECO:0000269|PubMed:17274988, ECO:0000269|PubMed:30061385, ECO:0000269|PubMed:33411331, ECO:0000269|PubMed:34646012, ECO:0000269|PubMed:34819673}. |
Download
reactome_id | name | p | -log10_p |
---|---|---|---|
R-HSA-9931521 | The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CL... | 0.000281 | 3.552 |
R-HSA-75153 | Apoptotic execution phase | 0.000316 | 3.501 |
R-HSA-69275 | G2/M Transition | 0.001408 | 2.851 |
R-HSA-453274 | Mitotic G2-G2/M phases | 0.001479 | 2.830 |
R-HSA-1640170 | Cell Cycle | 0.001225 | 2.912 |
R-HSA-69206 | G1/S Transition | 0.001505 | 2.822 |
R-HSA-9931510 | Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock gene... | 0.000948 | 3.023 |
R-HSA-9909396 | Circadian clock | 0.001916 | 2.718 |
R-HSA-9700649 | Drug resistance of ALK mutants | 0.005882 | 2.230 |
R-HSA-9717301 | NVP-TAE684-resistant ALK mutants | 0.005882 | 2.230 |
R-HSA-9717319 | brigatinib-resistant ALK mutants | 0.005882 | 2.230 |
R-HSA-9717316 | alectinib-resistant ALK mutants | 0.005882 | 2.230 |
R-HSA-9717323 | ceritinib-resistant ALK mutants | 0.005882 | 2.230 |
R-HSA-9717264 | ASP-3026-resistant ALK mutants | 0.005882 | 2.230 |
R-HSA-9717326 | crizotinib-resistant ALK mutants | 0.005882 | 2.230 |
R-HSA-9717329 | lorlatinib-resistant ALK mutants | 0.005882 | 2.230 |
R-HSA-9931530 | Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | 0.004146 | 2.382 |
R-HSA-2565942 | Regulation of PLK1 Activity at G2/M Transition | 0.002244 | 2.649 |
R-HSA-6794361 | Neurexins and neuroligins | 0.005547 | 2.256 |
R-HSA-9700206 | Signaling by ALK in cancer | 0.005570 | 2.254 |
R-HSA-9725370 | Signaling by ALK fusions and activated point mutants | 0.005570 | 2.254 |
R-HSA-69278 | Cell Cycle, Mitotic | 0.002484 | 2.605 |
R-HSA-453279 | Mitotic G1 phase and G1/S transition | 0.002974 | 2.527 |
R-HSA-109581 | Apoptosis | 0.004402 | 2.356 |
R-HSA-380284 | Loss of proteins required for interphase microtubule organization from the centr... | 0.008775 | 2.057 |
R-HSA-380259 | Loss of Nlp from mitotic centrosomes | 0.008775 | 2.057 |
R-HSA-4419969 | Depolymerization of the Nuclear Lamina | 0.008341 | 2.079 |
R-HSA-156711 | Polo-like kinase mediated events | 0.008341 | 2.079 |
R-HSA-9759194 | Nuclear events mediated by NFE2L2 | 0.008594 | 2.066 |
R-HSA-8854518 | AURKA Activation by TPX2 | 0.009811 | 2.008 |
R-HSA-2995383 | Initiation of Nuclear Envelope (NE) Reformation | 0.011320 | 1.946 |
R-HSA-9825892 | Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | 0.011320 | 1.946 |
R-HSA-5357801 | Programmed Cell Death | 0.010939 | 1.961 |
R-HSA-380270 | Recruitment of mitotic centrosome proteins and complexes | 0.012493 | 1.903 |
R-HSA-380287 | Centrosome maturation | 0.013330 | 1.875 |
R-HSA-204998 | Cell death signalling via NRAGE, NRIF and NADE | 0.012493 | 1.903 |
R-HSA-933542 | TRAF6 mediated NF-kB activation | 0.013817 | 1.860 |
R-HSA-6796648 | TP53 Regulates Transcription of DNA Repair Genes | 0.014642 | 1.834 |
R-HSA-9022699 | MECP2 regulates neuronal receptors and channels | 0.015602 | 1.807 |
R-HSA-380320 | Recruitment of NuMA to mitotic centrosomes | 0.020065 | 1.698 |
R-HSA-5620912 | Anchoring of the basal body to the plasma membrane | 0.021154 | 1.675 |
R-HSA-68962 | Activation of the pre-replicative complex | 0.019449 | 1.711 |
R-HSA-6794362 | Protein-protein interactions at synapses | 0.017982 | 1.745 |
R-HSA-9755511 | KEAP1-NFE2L2 pathway | 0.018164 | 1.741 |
R-HSA-111465 | Apoptotic cleavage of cellular proteins | 0.021506 | 1.667 |
R-HSA-9673768 | Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | 0.040464 | 1.393 |
R-HSA-69478 | G2/M DNA replication checkpoint | 0.051725 | 1.286 |
R-HSA-113507 | E2F-enabled inhibition of pre-replication complex formation | 0.051725 | 1.286 |
R-HSA-428890 | Role of ABL in ROBO-SLIT signaling | 0.057306 | 1.242 |
R-HSA-111367 | SLBP independent Processing of Histone Pre-mRNAs | 0.057306 | 1.242 |
R-HSA-446107 | Type I hemidesmosome assembly | 0.062855 | 1.202 |
R-HSA-9700645 | ALK mutants bind TKIs | 0.068371 | 1.165 |
R-HSA-933543 | NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | 0.079308 | 1.101 |
R-HSA-9931512 | Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | 0.084728 | 1.072 |
R-HSA-5651801 | PCNA-Dependent Long Patch Base Excision Repair | 0.126971 | 0.896 |
R-HSA-174048 | APC/C:Cdc20 mediated degradation of Cyclin B | 0.132113 | 0.879 |
R-HSA-5696397 | Gap-filling DNA repair synthesis and ligation in GG-NER | 0.147362 | 0.832 |
R-HSA-72649 | Translation initiation complex formation | 0.052306 | 1.281 |
R-HSA-72702 | Ribosomal scanning and start codon recognition | 0.055319 | 1.257 |
R-HSA-6782210 | Gap-filling DNA repair synthesis and ligation in TC-NER | 0.055319 | 1.257 |
R-HSA-6782135 | Dual incision in TC-NER | 0.058392 | 1.234 |
R-HSA-167243 | Tat-mediated HIV elongation arrest and recovery | 0.177070 | 0.752 |
R-HSA-167238 | Pausing and recovery of Tat-mediated HIV elongation | 0.177070 | 0.752 |
R-HSA-167287 | HIV elongation arrest and recovery | 0.181921 | 0.740 |
R-HSA-167290 | Pausing and recovery of HIV elongation | 0.181921 | 0.740 |
R-HSA-72689 | Formation of a pool of free 40S subunits | 0.025218 | 1.598 |
R-HSA-72706 | GTP hydrolysis and joining of the 60S ribosomal subunit | 0.034518 | 1.462 |
R-HSA-390522 | Striated Muscle Contraction | 0.210436 | 0.677 |
R-HSA-9948299 | Ribosome-associated quality control | 0.232645 | 0.633 |
R-HSA-9843970 | Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | 0.215092 | 0.667 |
R-HSA-6791226 | Major pathway of rRNA processing in the nucleolus and cytosol | 0.101554 | 0.993 |
R-HSA-9954709 | Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | 0.129900 | 0.886 |
R-HSA-174411 | Polymerase switching on the C-strand of the telomere | 0.167283 | 0.777 |
R-HSA-6807505 | RNA polymerase II transcribes snRNA genes | 0.108641 | 0.964 |
R-HSA-73856 | RNA Polymerase II Transcription Termination | 0.063111 | 1.200 |
R-HSA-9851151 | MDK and PTN in ALK signaling | 0.034784 | 1.459 |
R-HSA-6781827 | Transcription-Coupled Nucleotide Excision Repair (TC-NER) | 0.086687 | 1.062 |
R-HSA-8849472 | PTK6 Down-Regulation | 0.040464 | 1.393 |
R-HSA-77588 | SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | 0.062855 | 1.202 |
R-HSA-156827 | L13a-mediated translational silencing of Ceruloplasmin expression | 0.034518 | 1.462 |
R-HSA-5696400 | Dual Incision in GG-NER | 0.215092 | 0.667 |
R-HSA-201556 | Signaling by ALK | 0.030576 | 1.515 |
R-HSA-9842860 | Regulation of endogenous retroelements | 0.143893 | 0.842 |
R-HSA-140342 | Apoptosis induced DNA fragmentation | 0.073855 | 1.132 |
R-HSA-72613 | Eukaryotic Translation Initiation | 0.042103 | 1.376 |
R-HSA-9820841 | M-decay: degradation of maternal mRNAs by maternally stored factors | 0.246932 | 0.607 |
R-HSA-9932298 | Degradation of CRY and PER proteins | 0.034305 | 1.465 |
R-HSA-72737 | Cap-dependent Translation Initiation | 0.042103 | 1.376 |
R-HSA-168928 | DDX58/IFIH1-mediated induction of interferon-alpha/beta | 0.127929 | 0.893 |
R-HSA-918233 | TRAF3-dependent IRF activation pathway | 0.116594 | 0.933 |
R-HSA-933541 | TRAF6 mediated IRF7 activation | 0.228898 | 0.640 |
R-HSA-176417 | Phosphorylation of Emi1 | 0.046111 | 1.336 |
R-HSA-68952 | DNA replication initiation | 0.073855 | 1.132 |
R-HSA-6803544 | Ion influx/efflux at host-pathogen interface | 0.073855 | 1.132 |
R-HSA-209560 | NF-kB is activated and signals survival | 0.084728 | 1.072 |
R-HSA-176412 | Phosphorylation of the APC/C | 0.111361 | 0.953 |
R-HSA-68949 | Orc1 removal from chromatin | 0.049354 | 1.307 |
R-HSA-110314 | Recognition of DNA damage by PCNA-containing replication complex | 0.162346 | 0.790 |
R-HSA-73863 | RNA Polymerase I Transcription Termination | 0.177070 | 0.752 |
R-HSA-211733 | Regulation of activated PAK-2p34 by proteasome mediated degradation | 0.196303 | 0.707 |
R-HSA-3301854 | Nuclear Pore Complex (NPC) Disassembly | 0.219721 | 0.658 |
R-HSA-167246 | Tat-mediated elongation of the HIV-1 transcript | 0.242463 | 0.615 |
R-HSA-427389 | ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | 0.242463 | 0.615 |
R-HSA-167152 | Formation of HIV elongation complex in the absence of HIV Tat | 0.242463 | 0.615 |
R-HSA-8868773 | rRNA processing in the nucleus and cytosol | 0.124027 | 0.906 |
R-HSA-193639 | p75NTR signals via NF-kB | 0.106096 | 0.974 |
R-HSA-2980766 | Nuclear Envelope Breakdown | 0.056848 | 1.245 |
R-HSA-936440 | Negative regulators of DDX58/IFIH1 signaling | 0.196303 | 0.707 |
R-HSA-209543 | p75NTR recruits signalling complexes | 0.090117 | 1.045 |
R-HSA-5696398 | Nucleotide Excision Repair | 0.152027 | 0.818 |
R-HSA-75067 | Processing of Capped Intronless Pre-mRNA | 0.162346 | 0.790 |
R-HSA-176814 | Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | 0.055319 | 1.257 |
R-HSA-69052 | Switching of origins to a post-replicative state | 0.083174 | 1.080 |
R-HSA-68877 | Mitotic Prometaphase | 0.037252 | 1.429 |
R-HSA-176409 | APC/C:Cdc20 mediated degradation of mitotic proteins | 0.053805 | 1.269 |
R-HSA-2500257 | Resolution of Sister Chromatid Cohesion | 0.189616 | 0.722 |
R-HSA-9844594 | Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | 0.242463 | 0.615 |
R-HSA-9843743 | Transcriptional regulation of brown and beige adipocyte differentiation | 0.242463 | 0.615 |
R-HSA-69002 | DNA Replication Pre-Initiation | 0.035241 | 1.453 |
R-HSA-9604323 | Negative regulation of NOTCH4 signaling | 0.031800 | 1.498 |
R-HSA-72695 | Formation of the ternary complex, and subsequently, the 43S complex | 0.040887 | 1.388 |
R-HSA-72662 | Activation of the mRNA upon binding of the cap-binding complex and eIFs, and sub... | 0.058392 | 1.234 |
R-HSA-350562 | Regulation of ornithine decarboxylase (ODC) | 0.201042 | 0.697 |
R-HSA-8854050 | FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | 0.219721 | 0.658 |
R-HSA-174113 | SCF-beta-TrCP mediated degradation of Emi1 | 0.219721 | 0.658 |
R-HSA-9646399 | Aggrephagy | 0.242463 | 0.615 |
R-HSA-5610780 | Degradation of GLI1 by the proteasome | 0.251375 | 0.600 |
R-HSA-68875 | Mitotic Prophase | 0.187493 | 0.727 |
R-HSA-72312 | rRNA processing | 0.186795 | 0.729 |
R-HSA-110373 | Resolution of AP sites via the multiple-nucleotide patch replacement pathway | 0.172191 | 0.764 |
R-HSA-69273 | Cyclin A/B1/B2 associated events during G2/M transition | 0.205753 | 0.687 |
R-HSA-9664873 | Pexophagy | 0.073855 | 1.132 |
R-HSA-453276 | Regulation of mitotic cell cycle | 0.079707 | 1.099 |
R-HSA-174143 | APC/C-mediated degradation of cell cycle proteins | 0.079707 | 1.099 |
R-HSA-205043 | NRIF signals cell death from the nucleus | 0.100801 | 0.997 |
R-HSA-9830674 | Formation of the ureteric bud | 0.157381 | 0.803 |
R-HSA-4641258 | Degradation of DVL | 0.228898 | 0.640 |
R-HSA-174417 | Telomere C-strand (Lagging Strand) Synthesis | 0.251375 | 0.600 |
R-HSA-68886 | M Phase | 0.032396 | 1.490 |
R-HSA-167169 | HIV Transcription Elongation | 0.242463 | 0.615 |
R-HSA-68867 | Assembly of the pre-replicative complex | 0.124008 | 0.907 |
R-HSA-2980767 | Activation of NIMA Kinases NEK9, NEK6, NEK7 | 0.051725 | 1.286 |
R-HSA-2465910 | MASTL Facilitates Mitotic Progression | 0.068371 | 1.165 |
R-HSA-2514853 | Condensation of Prometaphase Chromosomes | 0.084728 | 1.072 |
R-HSA-877312 | Regulation of IFNG signaling | 0.090117 | 1.045 |
R-HSA-113510 | E2F mediated regulation of DNA replication | 0.132113 | 0.879 |
R-HSA-429947 | Deadenylation of mRNA | 0.162346 | 0.790 |
R-HSA-180585 | Vif-mediated degradation of APOBEC3G | 0.224323 | 0.649 |
R-HSA-450408 | AUF1 (hnRNP D0) binds and destabilizes mRNA | 0.224323 | 0.649 |
R-HSA-4641257 | Degradation of AXIN | 0.228898 | 0.640 |
R-HSA-9762114 | GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | 0.228898 | 0.640 |
R-HSA-774815 | Nucleosome assembly | 0.268889 | 0.570 |
R-HSA-606279 | Deposition of new CENPA-containing nucleosomes at the centromere | 0.268889 | 0.570 |
R-HSA-5656169 | Termination of translesion DNA synthesis | 0.186743 | 0.729 |
R-HSA-176408 | Regulation of APC/C activators between G1/S and early anaphase | 0.064711 | 1.189 |
R-HSA-73864 | RNA Polymerase I Transcription | 0.092039 | 1.036 |
R-HSA-9663891 | Selective autophagy | 0.112433 | 0.949 |
R-HSA-69306 | DNA Replication | 0.080944 | 1.092 |
R-HSA-446388 | Regulation of cytoskeletal remodeling and cell spreading by IPP complex componen... | 0.046111 | 1.336 |
R-HSA-75035 | Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | 0.095475 | 1.020 |
R-HSA-912694 | Regulation of IFNA/IFNB signaling | 0.152386 | 0.817 |
R-HSA-8852276 | The role of GTSE1 in G2/M progression after G2 checkpoint | 0.064711 | 1.189 |
R-HSA-180534 | Vpu mediated degradation of CD4 | 0.210436 | 0.677 |
R-HSA-75815 | Ubiquitin-dependent degradation of Cyclin D | 0.215092 | 0.667 |
R-HSA-349425 | Autodegradation of the E3 ubiquitin ligase COP1 | 0.215092 | 0.667 |
R-HSA-169911 | Regulation of Apoptosis | 0.219721 | 0.658 |
R-HSA-167200 | Formation of HIV-1 elongation complex containing HIV-1 Tat | 0.237968 | 0.623 |
R-HSA-5610785 | GLI3 is processed to GLI3R by the proteasome | 0.251375 | 0.600 |
R-HSA-5610783 | Degradation of GLI2 by the proteasome | 0.251375 | 0.600 |
R-HSA-5205685 | PINK1-PRKN Mediated Mitophagy | 0.181921 | 0.740 |
R-HSA-69239 | Synthesis of DNA | 0.033802 | 1.471 |
R-HSA-193704 | p75 NTR receptor-mediated signalling | 0.027716 | 1.557 |
R-HSA-8939902 | Regulation of RUNX2 expression and activity | 0.063111 | 1.200 |
R-HSA-162658 | Golgi Cisternae Pericentriolar Stack Reorganization | 0.095475 | 1.020 |
R-HSA-5661270 | Formation of xylulose-5-phosphate | 0.116594 | 0.933 |
R-HSA-77387 | Insulin receptor recycling | 0.181921 | 0.740 |
R-HSA-9833109 | Evasion by RSV of host interferon responses | 0.196303 | 0.707 |
R-HSA-9929491 | SPOP-mediated proteasomal degradation of PD-L1(CD274) | 0.246932 | 0.607 |
R-HSA-5362768 | Hh mutants are degraded by ERAD | 0.246932 | 0.607 |
R-HSA-73762 | RNA Polymerase I Transcription Initiation | 0.255792 | 0.592 |
R-HSA-5617833 | Cilium Assembly | 0.126629 | 0.897 |
R-HSA-73886 | Chromosome Maintenance | 0.189616 | 0.722 |
R-HSA-68882 | Mitotic Anaphase | 0.051531 | 1.288 |
R-HSA-9659379 | Sensory processing of sound | 0.093844 | 1.028 |
R-HSA-2555396 | Mitotic Metaphase and Anaphase | 0.052182 | 1.282 |
R-HSA-9907900 | Proteasome assembly | 0.264549 | 0.577 |
R-HSA-9010553 | Regulation of expression of SLITs and ROBOs | 0.265317 | 0.576 |
R-HSA-193648 | NRAGE signals death through JNK | 0.055319 | 1.257 |
R-HSA-9662360 | Sensory processing of sound by inner hair cells of the cochlea | 0.074595 | 1.127 |
R-HSA-9929356 | GSK3B-mediated proteasomal degradation of PD-L1(CD274) | 0.237968 | 0.623 |
R-HSA-1236978 | Cross-presentation of soluble exogenous antigens (endosomes) | 0.237968 | 0.623 |
R-HSA-5387390 | Hh mutants abrogate ligand secretion | 0.260183 | 0.585 |
R-HSA-187577 | SCF(Skp2)-mediated degradation of p27/p21 | 0.264549 | 0.577 |
R-HSA-4608870 | Asymmetric localization of PCP proteins | 0.268889 | 0.570 |
R-HSA-69620 | Cell Cycle Checkpoints | 0.226217 | 0.645 |
R-HSA-73933 | Resolution of Abasic Sites (AP sites) | 0.246932 | 0.607 |
R-HSA-5205647 | Mitophagy | 0.215092 | 0.667 |
R-HSA-69242 | S Phase | 0.075581 | 1.122 |
R-HSA-6798163 | Choline catabolism | 0.121798 | 0.914 |
R-HSA-9662361 | Sensory processing of sound by outer hair cells of the cochlea | 0.055319 | 1.257 |
R-HSA-70635 | Urea cycle | 0.172191 | 0.764 |
R-HSA-5678895 | Defective CFTR causes cystic fibrosis | 0.268889 | 0.570 |
R-HSA-69481 | G2/M Checkpoints | 0.204566 | 0.689 |
R-HSA-1632852 | Macroautophagy | 0.239165 | 0.621 |
R-HSA-936837 | Ion transport by P-type ATPases | 0.067954 | 1.168 |
R-HSA-376176 | Signaling by ROBO receptors | 0.144008 | 0.842 |
R-HSA-8941858 | Regulation of RUNX3 expression and activity | 0.242463 | 0.615 |
R-HSA-5676590 | NIK-->noncanonical NF-kB signaling | 0.246932 | 0.607 |
R-HSA-5607761 | Dectin-1 mediated noncanonical NF-kB signaling | 0.268889 | 0.570 |
R-HSA-9711123 | Cellular response to chemical stress | 0.028243 | 1.549 |
R-HSA-982772 | Growth hormone receptor signaling | 0.157381 | 0.803 |
R-HSA-8953854 | Metabolism of RNA | 0.241241 | 0.618 |
R-HSA-264870 | Caspase-mediated cleavage of cytoskeletal proteins | 0.068371 | 1.165 |
R-HSA-446353 | Cell-extracellular matrix interactions | 0.106096 | 0.974 |
R-HSA-9013694 | Signaling by NOTCH4 | 0.084925 | 1.071 |
R-HSA-6804114 | TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | 0.116594 | 0.933 |
R-HSA-3214841 | PKMTs methylate histone lysines | 0.246932 | 0.607 |
R-HSA-69613 | p53-Independent G1/S DNA Damage Checkpoint | 0.268889 | 0.570 |
R-HSA-69601 | Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | 0.268889 | 0.570 |
R-HSA-9706369 | Negative regulation of FLT3 | 0.111361 | 0.953 |
R-HSA-6807004 | Negative regulation of MET activity | 0.137226 | 0.863 |
R-HSA-9671555 | Signaling by PDGFR in disease | 0.147362 | 0.832 |
R-HSA-2995410 | Nuclear Envelope (NE) Reassembly | 0.095660 | 1.019 |
R-HSA-199977 | ER to Golgi Anterograde Transport | 0.254411 | 0.594 |
R-HSA-73887 | Death Receptor Signaling | 0.082037 | 1.086 |
R-HSA-8878166 | Transcriptional regulation by RUNX2 | 0.044530 | 1.351 |
R-HSA-69205 | G1/S-Specific Transcription | 0.027023 | 1.568 |
R-HSA-6804115 | TP53 regulates transcription of additional cell cycle genes whose exact role in ... | 0.152386 | 0.817 |
R-HSA-6804758 | Regulation of TP53 Activity through Acetylation | 0.205753 | 0.687 |
R-HSA-9818027 | NFE2L2 regulating anti-oxidant/detoxification enzymes | 0.210436 | 0.677 |
R-HSA-5689896 | Ovarian tumor domain proteases | 0.228898 | 0.640 |
R-HSA-110313 | Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA templa... | 0.246932 | 0.607 |
R-HSA-9013507 | NOTCH3 Activation and Transmission of Signal to the Nucleus | 0.152386 | 0.817 |
R-HSA-416482 | G alpha (12/13) signalling events | 0.092039 | 1.036 |
R-HSA-69541 | Stabilization of p53 | 0.237968 | 0.623 |
R-HSA-71064 | Lysine catabolism | 0.228898 | 0.640 |
R-HSA-983712 | Ion channel transport | 0.125326 | 0.902 |
R-HSA-70263 | Gluconeogenesis | 0.043642 | 1.360 |
R-HSA-6807070 | PTEN Regulation | 0.234817 | 0.629 |
R-HSA-9824272 | Somitogenesis | 0.268889 | 0.570 |
R-HSA-70326 | Glucose metabolism | 0.181145 | 0.742 |
R-HSA-446728 | Cell junction organization | 0.257562 | 0.589 |
R-HSA-74160 | Gene expression (Transcription) | 0.073990 | 1.131 |
R-HSA-5663202 | Diseases of signal transduction by growth factor receptors and second messengers | 0.097650 | 1.010 |
R-HSA-6791312 | TP53 Regulates Transcription of Cell Cycle Genes | 0.056848 | 1.245 |
R-HSA-73857 | RNA Polymerase II Transcription | 0.077876 | 1.109 |
R-HSA-9860927 | Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZ... | 0.219721 | 0.658 |
R-HSA-70171 | Glycolysis | 0.139862 | 0.854 |
R-HSA-354192 | Integrin signaling | 0.205753 | 0.687 |
R-HSA-8853659 | RET signaling | 0.224323 | 0.649 |
R-HSA-76009 | Platelet Aggregation (Plug Formation) | 0.268889 | 0.570 |
R-HSA-9020702 | Interleukin-1 signaling | 0.141875 | 0.848 |
R-HSA-196757 | Metabolism of folate and pterines | 0.228898 | 0.640 |
R-HSA-9725371 | Nuclear events stimulated by ALK signaling in cancer | 0.043642 | 1.360 |
R-HSA-3700989 | Transcriptional Regulation by TP53 | 0.068118 | 1.167 |
R-HSA-422475 | Axon guidance | 0.242356 | 0.616 |
R-HSA-8986944 | Transcriptional Regulation by MECP2 | 0.118184 | 0.927 |
R-HSA-9607240 | FLT3 Signaling | 0.246932 | 0.607 |
R-HSA-446652 | Interleukin-1 family signaling | 0.265317 | 0.576 |
R-HSA-9856651 | MITF-M-dependent gene expression | 0.260954 | 0.583 |
R-HSA-174084 | Autodegradation of Cdh1 by Cdh1:APC/C | 0.273204 | 0.564 |
R-HSA-6781823 | Formation of TC-NER Pre-Incision Complex | 0.273204 | 0.564 |
R-HSA-2299718 | Condensation of Prophase Chromosomes | 0.273204 | 0.564 |
R-HSA-9612973 | Autophagy | 0.274045 | 0.562 |
R-HSA-72766 | Translation | 0.274869 | 0.561 |
R-HSA-174154 | APC/C:Cdc20 mediated degradation of Securin | 0.277494 | 0.557 |
R-HSA-6811440 | Retrograde transport at the Trans-Golgi-Network | 0.277494 | 0.557 |
R-HSA-9675108 | Nervous system development | 0.283790 | 0.547 |
R-HSA-73893 | DNA Damage Bypass | 0.285998 | 0.544 |
R-HSA-9766229 | Degradation of CDH1 | 0.285998 | 0.544 |
R-HSA-69563 | p53-Dependent G1 DNA Damage Response | 0.285998 | 0.544 |
R-HSA-69580 | p53-Dependent G1/S DNA damage checkpoint | 0.285998 | 0.544 |
R-HSA-5658442 | Regulation of RAS by GAPs | 0.290213 | 0.537 |
R-HSA-2467813 | Separation of Sister Chromatids | 0.291485 | 0.535 |
R-HSA-1169091 | Activation of NF-kappaB in B cells | 0.294403 | 0.531 |
R-HSA-1234176 | Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | 0.294403 | 0.531 |
R-HSA-5358346 | Hedgehog ligand biogenesis | 0.294403 | 0.531 |
R-HSA-72187 | mRNA 3'-end processing | 0.298569 | 0.525 |
R-HSA-112382 | Formation of RNA Pol II elongation complex | 0.298569 | 0.525 |
R-HSA-174184 | Cdc20:Phospho-APC/C mediated degradation of Cyclin A | 0.298569 | 0.525 |
R-HSA-9931269 | AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | 0.298569 | 0.525 |
R-HSA-9692916 | SARS-CoV-1 activates/modulates innate immune responses | 0.298569 | 0.525 |
R-HSA-75955 | RNA Polymerase II Transcription Elongation | 0.302710 | 0.519 |
R-HSA-174178 | APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins ... | 0.302710 | 0.519 |
R-HSA-179419 | APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of th... | 0.302710 | 0.519 |
R-HSA-8948751 | Regulation of PTEN stability and activity | 0.302710 | 0.519 |
R-HSA-69017 | CDK-mediated phosphorylation and removal of Cdc6 | 0.306827 | 0.513 |
R-HSA-3214815 | HDACs deacetylate histones | 0.310921 | 0.507 |
R-HSA-6811436 | COPI-independent Golgi-to-ER retrograde traffic | 0.310921 | 0.507 |
R-HSA-9012852 | Signaling by NOTCH3 | 0.310921 | 0.507 |
R-HSA-6798695 | Neutrophil degranulation | 0.311882 | 0.506 |
R-HSA-3299685 | Detoxification of Reactive Oxygen Species | 0.314990 | 0.502 |
R-HSA-1500931 | Cell-Cell communication | 0.318455 | 0.497 |
R-HSA-9764561 | Regulation of CDH1 Function | 0.319035 | 0.496 |
R-HSA-212436 | Generic Transcription Pathway | 0.322940 | 0.491 |
R-HSA-1852241 | Organelle biogenesis and maintenance | 0.324910 | 0.488 |
R-HSA-180786 | Extension of Telomeres | 0.327056 | 0.485 |
R-HSA-429914 | Deadenylation-dependent mRNA decay | 0.327056 | 0.485 |
R-HSA-2022090 | Assembly of collagen fibrils and other multimeric structures | 0.327056 | 0.485 |
R-HSA-9845323 | Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | 0.331031 | 0.480 |
R-HSA-8943724 | Regulation of PTEN gene transcription | 0.331031 | 0.480 |
R-HSA-156590 | Glutathione conjugation | 0.331031 | 0.480 |
R-HSA-351202 | Metabolism of polyamines | 0.331031 | 0.480 |
R-HSA-9793380 | Formation of paraxial mesoderm | 0.334982 | 0.475 |
R-HSA-6790901 | rRNA modification in the nucleus and cytosol | 0.342817 | 0.465 |
R-HSA-69615 | G1/S DNA Damage Checkpoints | 0.342817 | 0.465 |
R-HSA-9006927 | Signaling by Non-Receptor Tyrosine Kinases | 0.342817 | 0.465 |
R-HSA-8848021 | Signaling by PTK6 | 0.342817 | 0.465 |
R-HSA-1234174 | Cellular response to hypoxia | 0.350560 | 0.455 |
R-HSA-9830369 | Kidney development | 0.358212 | 0.446 |
R-HSA-5685942 | HDR through Homologous Recombination (HRR) | 0.358212 | 0.446 |
R-HSA-167172 | Transcription of the HIV genome | 0.362005 | 0.441 |
R-HSA-3371497 | HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of lig... | 0.362005 | 0.441 |
R-HSA-9843940 | Regulation of endogenous retroelements by KRAB-ZFP proteins | 0.369524 | 0.432 |
R-HSA-1168372 | Downstream signaling events of B Cell Receptor (BCR) | 0.369524 | 0.432 |
R-HSA-204005 | COPII-mediated vesicle transport | 0.369524 | 0.432 |
R-HSA-69202 | Cyclin E associated events during G1/S transition | 0.369524 | 0.432 |
R-HSA-195253 | Degradation of beta-catenin by the destruction complex | 0.369524 | 0.432 |
R-HSA-6811442 | Intra-Golgi and retrograde Golgi-to-ER traffic | 0.371046 | 0.431 |
R-HSA-5250913 | Positive epigenetic regulation of rRNA expression | 0.373251 | 0.428 |
R-HSA-5632684 | Hedgehog 'on' state | 0.373251 | 0.428 |
R-HSA-948021 | Transport to the Golgi and subsequent modification | 0.375261 | 0.426 |
R-HSA-69656 | Cyclin A:Cdk2-associated events at S phase entry | 0.376956 | 0.424 |
R-HSA-450531 | Regulation of mRNA stability by proteins that bind AU-rich elements | 0.376956 | 0.424 |
R-HSA-2454202 | Fc epsilon receptor (FCERI) signaling | 0.377365 | 0.423 |
R-HSA-159236 | Transport of Mature mRNA derived from an Intron-Containing Transcript | 0.380639 | 0.419 |
R-HSA-8953897 | Cellular responses to stimuli | 0.382478 | 0.417 |
R-HSA-674695 | RNA Polymerase II Pre-transcription Events | 0.384301 | 0.415 |
R-HSA-69473 | G2/M DNA damage checkpoint | 0.384301 | 0.415 |
R-HSA-5689603 | UCH proteinases | 0.391560 | 0.407 |
R-HSA-73854 | RNA Polymerase I Promoter Clearance | 0.391560 | 0.407 |
R-HSA-5619084 | ABC transporter disorders | 0.398734 | 0.399 |
R-HSA-4086400 | PCP/CE pathway | 0.398734 | 0.399 |
R-HSA-9730414 | MITF-M-regulated melanocyte development | 0.400310 | 0.398 |
R-HSA-168249 | Innate Immune System | 0.402165 | 0.396 |
R-HSA-9833482 | PKR-mediated signaling | 0.405825 | 0.392 |
R-HSA-6806834 | Signaling by MET | 0.405825 | 0.392 |
R-HSA-72202 | Transport of Mature Transcript to Cytoplasm | 0.412833 | 0.384 |
R-HSA-2262752 | Cellular responses to stress | 0.415152 | 0.382 |
R-HSA-5668541 | TNFR2 non-canonical NF-kB pathway | 0.416306 | 0.381 |
R-HSA-8951664 | Neddylation | 0.416754 | 0.380 |
R-HSA-5696399 | Global Genome Nucleotide Excision Repair (GG-NER) | 0.419759 | 0.377 |
R-HSA-8939236 | RUNX1 regulates transcription of genes involved in differentiation of HSCs | 0.419759 | 0.377 |
R-HSA-5687128 | MAPK6/MAPK4 signaling | 0.423192 | 0.373 |
R-HSA-141444 | Amplification of signal from unattached kinetochores via a MAD2 inhibitory si... | 0.426605 | 0.370 |
R-HSA-141424 | Amplification of signal from the kinetochores | 0.426605 | 0.370 |
R-HSA-9909615 | Regulation of PD-L1(CD274) Post-translational modification | 0.426605 | 0.370 |
R-HSA-162906 | HIV Infection | 0.428941 | 0.368 |
R-HSA-156902 | Peptide chain elongation | 0.436723 | 0.360 |
R-HSA-1236974 | ER-Phagosome pathway | 0.440057 | 0.356 |
R-HSA-3247509 | Chromatin modifying enzymes | 0.442991 | 0.354 |
R-HSA-73884 | Base Excision Repair | 0.443370 | 0.353 |
R-HSA-202424 | Downstream TCR signaling | 0.443370 | 0.353 |
R-HSA-9954714 | PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | 0.446665 | 0.350 |
R-HSA-975956 | Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | 0.449940 | 0.347 |
R-HSA-156842 | Eukaryotic Translation Elongation | 0.453196 | 0.344 |
R-HSA-74752 | Signaling by Insulin receptor | 0.453196 | 0.344 |
R-HSA-157118 | Signaling by NOTCH | 0.454885 | 0.342 |
R-HSA-1474290 | Collagen formation | 0.459651 | 0.338 |
R-HSA-9954716 | ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ri... | 0.462850 | 0.335 |
R-HSA-72764 | Eukaryotic Translation Termination | 0.466031 | 0.332 |
R-HSA-6807878 | COPI-mediated anterograde transport | 0.469192 | 0.329 |
R-HSA-5607764 | CLEC7A (Dectin-1) signaling | 0.469192 | 0.329 |
R-HSA-157579 | Telomere Maintenance | 0.472335 | 0.326 |
R-HSA-8878159 | Transcriptional regulation by RUNX3 | 0.472335 | 0.326 |
R-HSA-4839726 | Chromatin organization | 0.472455 | 0.326 |
R-HSA-975871 | MyD88 cascade initiated on plasma membrane | 0.475460 | 0.323 |
R-HSA-168142 | Toll Like Receptor 10 (TLR10) Cascade | 0.475460 | 0.323 |
R-HSA-168176 | Toll Like Receptor 5 (TLR5) Cascade | 0.475460 | 0.323 |
R-HSA-69618 | Mitotic Spindle Checkpoint | 0.481655 | 0.317 |
R-HSA-5610787 | Hedgehog 'off' state | 0.481655 | 0.317 |
R-HSA-382556 | ABC-family proteins mediated transport | 0.481655 | 0.317 |
R-HSA-5688426 | Deubiquitination | 0.483981 | 0.315 |
R-HSA-2408557 | Selenocysteine synthesis | 0.484725 | 0.315 |
R-HSA-192823 | Viral mRNA Translation | 0.490812 | 0.309 |
R-HSA-9633012 | Response of EIF2AK4 (GCN2) to amino acid deficiency | 0.493828 | 0.306 |
R-HSA-8856825 | Cargo recognition for clathrin-mediated endocytosis | 0.493828 | 0.306 |
R-HSA-9860931 | Response of endothelial cells to shear stress | 0.493828 | 0.306 |
R-HSA-9833110 | RSV-host interactions | 0.496827 | 0.304 |
R-HSA-9692914 | SARS-CoV-1-host interactions | 0.502772 | 0.299 |
R-HSA-1799339 | SRP-dependent cotranslational protein targeting to membrane | 0.505718 | 0.296 |
R-HSA-1236975 | Antigen processing-Cross presentation | 0.508648 | 0.294 |
R-HSA-2672351 | Stimuli-sensing channels | 0.508648 | 0.294 |
R-HSA-975138 | TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | 0.508648 | 0.294 |
R-HSA-9648025 | EML4 and NUDC in mitotic spindle formation | 0.511559 | 0.291 |
R-HSA-975155 | MyD88 dependent cascade initiated on endosome | 0.511559 | 0.291 |
R-HSA-202403 | TCR signaling | 0.514454 | 0.289 |
R-HSA-6803157 | Antimicrobial peptides | 0.517332 | 0.286 |
R-HSA-76002 | Platelet activation, signaling and aggregation | 0.519452 | 0.284 |
R-HSA-927802 | Nonsense-Mediated Decay (NMD) | 0.520193 | 0.284 |
R-HSA-975957 | Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | 0.520193 | 0.284 |
R-HSA-2871796 | FCERI mediated MAPK activation | 0.520193 | 0.284 |
R-HSA-168181 | Toll Like Receptor 7/8 (TLR7/8) Cascade | 0.523037 | 0.281 |
R-HSA-71291 | Metabolism of amino acids and derivatives | 0.523527 | 0.281 |
R-HSA-5693567 | HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | 0.525865 | 0.279 |
R-HSA-9855142 | Cellular responses to mechanical stimuli | 0.525865 | 0.279 |
R-HSA-168138 | Toll Like Receptor 9 (TLR9) Cascade | 0.531470 | 0.275 |
R-HSA-909733 | Interferon alpha/beta signaling | 0.534248 | 0.272 |
R-HSA-71387 | Metabolism of carbohydrates and carbohydrate derivatives | 0.535378 | 0.271 |
R-HSA-373760 | L1CAM interactions | 0.537010 | 0.270 |
R-HSA-5693538 | Homology Directed Repair | 0.542485 | 0.266 |
R-HSA-166058 | MyD88:MAL(TIRAP) cascade initiated on plasma membrane | 0.545199 | 0.263 |
R-HSA-168188 | Toll Like Receptor TLR6:TLR2 Cascade | 0.545199 | 0.263 |
R-HSA-168179 | Toll Like Receptor TLR1:TLR2 Cascade | 0.553244 | 0.257 |
R-HSA-181438 | Toll Like Receptor 2 (TLR2) Cascade | 0.553244 | 0.257 |
R-HSA-112316 | Neuronal System | 0.553701 | 0.257 |
R-HSA-9816359 | Maternal to zygotic transition (MZT) | 0.555894 | 0.255 |
R-HSA-2132295 | MHC class II antigen presentation | 0.555894 | 0.255 |
R-HSA-1257604 | PIP3 activates AKT signaling | 0.556755 | 0.254 |
R-HSA-162909 | Host Interactions of HIV factors | 0.558529 | 0.253 |
R-HSA-199991 | Membrane Trafficking | 0.560047 | 0.252 |
R-HSA-114608 | Platelet degranulation | 0.568914 | 0.245 |
R-HSA-9843745 | Adipogenesis | 0.581556 | 0.235 |
R-HSA-8856688 | Golgi-to-ER retrograde transport | 0.584040 | 0.234 |
R-HSA-76005 | Response to elevated platelet cytosolic Ca2+ | 0.586510 | 0.232 |
R-HSA-3858494 | Beta-catenin independent WNT signaling | 0.596243 | 0.225 |
R-HSA-9820952 | Respiratory Syncytial Virus Infection Pathway | 0.598641 | 0.223 |
R-HSA-5358351 | Signaling by Hedgehog | 0.601024 | 0.221 |
R-HSA-212165 | Epigenetic regulation of gene expression | 0.603274 | 0.219 |
R-HSA-9664417 | Leishmania phagocytosis | 0.605750 | 0.218 |
R-HSA-9664407 | Parasite infection | 0.605750 | 0.218 |
R-HSA-9664422 | FCGR3A-mediated phagocytosis | 0.605750 | 0.218 |
R-HSA-2029482 | Regulation of actin dynamics for phagocytic cup formation | 0.608092 | 0.216 |
R-HSA-162599 | Late Phase of HIV Life Cycle | 0.612734 | 0.213 |
R-HSA-9705671 | SARS-CoV-2 activates/modulates innate and adaptive immune responses | 0.612734 | 0.213 |
R-HSA-8856828 | Clathrin-mediated endocytosis | 0.615035 | 0.211 |
R-HSA-2871837 | FCERI mediated NF-kB activation | 0.617322 | 0.209 |
R-HSA-166016 | Toll Like Receptor 4 (TLR4) Cascade | 0.626338 | 0.203 |
R-HSA-9758941 | Gastrulation | 0.628559 | 0.202 |
R-HSA-9679191 | Potential therapeutics for SARS | 0.630766 | 0.200 |
R-HSA-9006925 | Intracellular signaling by second messengers | 0.632719 | 0.199 |
R-HSA-5693532 | DNA Double-Strand Break Repair | 0.637312 | 0.196 |
R-HSA-1169410 | Antiviral mechanism by IFN-stimulated genes | 0.639468 | 0.194 |
R-HSA-168273 | Influenza Viral RNA Transcription and Replication | 0.641612 | 0.193 |
R-HSA-162587 | HIV Life Cycle | 0.645862 | 0.190 |
R-HSA-9711097 | Cellular response to starvation | 0.647967 | 0.188 |
R-HSA-983705 | Signaling by the B Cell Receptor (BCR) | 0.647967 | 0.188 |
R-HSA-877300 | Interferon gamma signaling | 0.650061 | 0.187 |
R-HSA-5633007 | Regulation of TP53 Activity | 0.652142 | 0.186 |
R-HSA-73894 | DNA Repair | 0.659038 | 0.181 |
R-HSA-2408522 | Selenoamino acid metabolism | 0.660346 | 0.180 |
R-HSA-5621481 | C-type lectin receptors (CLRs) | 0.676182 | 0.170 |
R-HSA-9909648 | Regulation of PD-L1(CD274) expression | 0.678110 | 0.169 |
R-HSA-9824446 | Viral Infection Pathways | 0.678257 | 0.169 |
R-HSA-5689880 | Ub-specific processing proteases | 0.680026 | 0.167 |
R-HSA-9764265 | Regulation of CDH1 Expression and Function | 0.680026 | 0.167 |
R-HSA-9764274 | Regulation of Expression and Function of Type I Classical Cadherins | 0.680026 | 0.167 |
R-HSA-2029480 | Fcgamma receptor (FCGR) dependent phagocytosis | 0.681931 | 0.166 |
R-HSA-9678108 | SARS-CoV-1 Infection | 0.683824 | 0.165 |
R-HSA-168255 | Influenza Infection | 0.691288 | 0.160 |
R-HSA-913531 | Interferon Signaling | 0.691787 | 0.160 |
R-HSA-201681 | TCF dependent signaling in response to WNT | 0.698577 | 0.156 |
R-HSA-168898 | Toll-like Receptor Cascades | 0.712648 | 0.147 |
R-HSA-9609690 | HCMV Early Events | 0.721111 | 0.142 |
R-HSA-9759476 | Regulation of Homotypic Cell-Cell Adhesion | 0.721111 | 0.142 |
R-HSA-5653656 | Vesicle-mediated transport | 0.726609 | 0.139 |
R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases | 0.727119 | 0.138 |
R-HSA-389948 | Co-inhibition by PD-1 | 0.727703 | 0.138 |
R-HSA-1266738 | Developmental Biology | 0.738274 | 0.132 |
R-HSA-446203 | Asparagine N-linked glycosylation | 0.739508 | 0.131 |
R-HSA-397014 | Muscle contraction | 0.748080 | 0.126 |
R-HSA-418990 | Adherens junctions interactions | 0.756969 | 0.121 |
R-HSA-8878171 | Transcriptional regulation by RUNX1 | 0.768339 | 0.114 |
R-HSA-9705683 | SARS-CoV-2-host interactions | 0.771099 | 0.113 |
R-HSA-196849 | Metabolism of water-soluble vitamins and cofactors | 0.773826 | 0.111 |
R-HSA-1280215 | Cytokine Signaling in Immune system | 0.781611 | 0.107 |
R-HSA-156580 | Phase II - Conjugation of compounds | 0.785704 | 0.105 |
R-HSA-5619115 | Disorders of transmembrane transporters | 0.795743 | 0.099 |
R-HSA-9609646 | HCMV Infection | 0.799387 | 0.097 |
R-HSA-421270 | Cell-cell junction organization | 0.800587 | 0.097 |
R-HSA-388841 | Regulation of T cell activation by CD28 family | 0.806482 | 0.093 |
R-HSA-72203 | Processing of Capped Intron-Containing Pre-mRNA | 0.831453 | 0.080 |
R-HSA-9658195 | Leishmania infection | 0.833467 | 0.079 |
R-HSA-9824443 | Parasitic Infection Pathways | 0.833467 | 0.079 |
R-HSA-983168 | Antigen processing: Ubiquitination & Proteasome degradation | 0.834465 | 0.079 |
R-HSA-5673001 | RAF/MAP kinase cascade | 0.841289 | 0.075 |
R-HSA-5684996 | MAPK1/MAPK3 signaling | 0.847834 | 0.072 |
R-HSA-382551 | Transport of small molecules | 0.849324 | 0.071 |
R-HSA-195721 | Signaling by WNT | 0.849655 | 0.071 |
R-HSA-9679506 | SARS-CoV Infections | 0.857861 | 0.067 |
R-HSA-1474244 | Extracellular matrix organization | 0.876761 | 0.057 |
R-HSA-5683057 | MAPK family signaling cascades | 0.888103 | 0.052 |
R-HSA-9694516 | SARS-CoV-2 Infection | 0.889446 | 0.051 |
R-HSA-5663205 | Infectious disease | 0.889631 | 0.051 |
R-HSA-449147 | Signaling by Interleukins | 0.898343 | 0.047 |
R-HSA-196854 | Metabolism of vitamins and cofactors | 0.899023 | 0.046 |
R-HSA-983169 | Class I MHC mediated antigen processing & presentation | 0.910527 | 0.041 |
R-HSA-168256 | Immune System | 0.916023 | 0.038 |
R-HSA-1643685 | Disease | 0.929482 | 0.032 |
R-HSA-162582 | Signal Transduction | 0.929584 | 0.032 |
R-HSA-597592 | Post-translational protein modification | 0.939684 | 0.027 |
R-HSA-388396 | GPCR downstream signalling | 0.951646 | 0.022 |
R-HSA-109582 | Hemostasis | 0.954056 | 0.020 |
R-HSA-392499 | Metabolism of proteins | 0.959970 | 0.018 |
R-HSA-211859 | Biological oxidations | 0.961796 | 0.017 |
R-HSA-372790 | Signaling by GPCR | 0.968503 | 0.014 |
R-HSA-1280218 | Adaptive Immune System | 0.988512 | 0.005 |
R-HSA-9709957 | Sensory Perception | 0.996013 | 0.002 |
R-HSA-1430728 | Metabolism | 0.999963 | 0.000 |
Download
kinase | JSD_mean | pearson_surrounding | kinase_max_IC_position | max_position_JSD |
---|---|---|---|---|
HIPK4 |
0.788 | 0.315 | 1 | 0.807 |
CLK3 |
0.785 | 0.240 | 1 | 0.823 |
PRKD1 |
0.777 | 0.266 | -3 | 0.844 |
SRPK1 |
0.774 | 0.209 | -3 | 0.803 |
HIPK2 |
0.771 | 0.269 | 1 | 0.719 |
COT |
0.770 | 0.040 | 2 | 0.729 |
CDC7 |
0.769 | 0.097 | 1 | 0.776 |
KIS |
0.766 | 0.150 | 1 | 0.752 |
DYRK2 |
0.766 | 0.241 | 1 | 0.781 |
CLK2 |
0.766 | 0.224 | -3 | 0.811 |
SRPK2 |
0.765 | 0.177 | -3 | 0.743 |
PRKD2 |
0.765 | 0.154 | -3 | 0.826 |
CDKL5 |
0.763 | 0.129 | -3 | 0.821 |
PIM3 |
0.763 | 0.073 | -3 | 0.868 |
MTOR |
0.762 | 0.112 | 1 | 0.761 |
NLK |
0.762 | 0.147 | 1 | 0.828 |
MOS |
0.762 | 0.075 | 1 | 0.788 |
SKMLCK |
0.762 | 0.157 | -2 | 0.479 |
NDR2 |
0.761 | 0.062 | -3 | 0.866 |
CDK8 |
0.761 | 0.186 | 1 | 0.747 |
CDK19 |
0.760 | 0.193 | 1 | 0.721 |
ERK5 |
0.760 | 0.103 | 1 | 0.776 |
CDK7 |
0.760 | 0.183 | 1 | 0.750 |
HIPK1 |
0.760 | 0.243 | 1 | 0.781 |
JNK2 |
0.760 | 0.247 | 1 | 0.718 |
CDKL1 |
0.759 | 0.113 | -3 | 0.828 |
CLK1 |
0.759 | 0.225 | -3 | 0.790 |
CDK18 |
0.758 | 0.200 | 1 | 0.692 |
PRPK |
0.758 | 0.055 | -1 | 0.838 |
ICK |
0.758 | 0.142 | -3 | 0.849 |
CLK4 |
0.756 | 0.167 | -3 | 0.804 |
MAPKAPK2 |
0.756 | 0.122 | -3 | 0.800 |
IKKB |
0.755 | -0.029 | -2 | 0.400 |
NUAK2 |
0.754 | 0.127 | -3 | 0.859 |
MARK4 |
0.754 | 0.151 | 4 | 0.784 |
MAPKAPK3 |
0.754 | 0.125 | -3 | 0.817 |
AURC |
0.754 | 0.031 | -2 | 0.293 |
RSK2 |
0.753 | 0.067 | -3 | 0.818 |
P38B |
0.753 | 0.193 | 1 | 0.717 |
CAMK1B |
0.753 | 0.052 | -3 | 0.855 |
DYRK4 |
0.753 | 0.227 | 1 | 0.733 |
BMPR1B |
0.753 | 0.092 | 1 | 0.758 |
RAF1 |
0.753 | -0.026 | 1 | 0.759 |
JNK3 |
0.752 | 0.227 | 1 | 0.739 |
RSK3 |
0.752 | 0.076 | -3 | 0.810 |
PIM1 |
0.752 | 0.084 | -3 | 0.834 |
IKKA |
0.751 | 0.015 | -2 | 0.421 |
DYRK1A |
0.751 | 0.205 | 1 | 0.786 |
SRPK3 |
0.751 | 0.130 | -3 | 0.775 |
P38A |
0.751 | 0.189 | 1 | 0.759 |
TBK1 |
0.751 | -0.013 | 1 | 0.659 |
HIPK3 |
0.750 | 0.238 | 1 | 0.764 |
CAMK2D |
0.750 | 0.081 | -3 | 0.837 |
CDK5 |
0.750 | 0.168 | 1 | 0.754 |
P90RSK |
0.750 | 0.076 | -3 | 0.810 |
CHAK2 |
0.750 | 0.050 | -1 | 0.771 |
IKKE |
0.749 | -0.015 | 1 | 0.662 |
CDK1 |
0.749 | 0.154 | 1 | 0.732 |
TGFBR2 |
0.749 | -0.036 | -2 | 0.417 |
P38G |
0.749 | 0.194 | 1 | 0.665 |
TSSK2 |
0.749 | 0.151 | -5 | 0.791 |
TSSK1 |
0.748 | 0.152 | -3 | 0.878 |
BMPR2 |
0.748 | -0.075 | -2 | 0.472 |
GRK1 |
0.748 | 0.007 | -2 | 0.383 |
PKN3 |
0.748 | 0.042 | -3 | 0.839 |
MST4 |
0.748 | 0.032 | 2 | 0.757 |
PDHK4 |
0.748 | -0.129 | 1 | 0.776 |
ERK1 |
0.748 | 0.169 | 1 | 0.711 |
CDK17 |
0.747 | 0.170 | 1 | 0.664 |
DAPK2 |
0.747 | 0.081 | -3 | 0.852 |
PRKD3 |
0.747 | 0.110 | -3 | 0.791 |
NDR1 |
0.747 | 0.001 | -3 | 0.856 |
CAMLCK |
0.747 | 0.032 | -2 | 0.438 |
ATR |
0.747 | -0.024 | 1 | 0.713 |
NEK6 |
0.746 | 0.000 | -2 | 0.474 |
DYRK1B |
0.746 | 0.202 | 1 | 0.738 |
CDK13 |
0.746 | 0.149 | 1 | 0.730 |
CAMK2A |
0.746 | 0.090 | 2 | 0.683 |
AMPKA1 |
0.746 | 0.090 | -3 | 0.864 |
GCN2 |
0.745 | -0.122 | 2 | 0.663 |
NIK |
0.745 | 0.028 | -3 | 0.858 |
DSTYK |
0.745 | -0.057 | 2 | 0.765 |
PKN2 |
0.745 | 0.033 | -3 | 0.849 |
QSK |
0.745 | 0.144 | 4 | 0.768 |
P38D |
0.744 | 0.195 | 1 | 0.663 |
AMPKA2 |
0.744 | 0.103 | -3 | 0.851 |
PKACB |
0.744 | 0.047 | -2 | 0.310 |
WNK1 |
0.744 | 0.033 | -2 | 0.485 |
LATS2 |
0.744 | 0.011 | -5 | 0.649 |
ULK2 |
0.744 | -0.061 | 2 | 0.647 |
MLK2 |
0.744 | 0.028 | 2 | 0.717 |
MAK |
0.743 | 0.202 | -2 | 0.456 |
PDHK1 |
0.743 | -0.104 | 1 | 0.759 |
RSK4 |
0.743 | 0.062 | -3 | 0.804 |
SIK |
0.742 | 0.136 | -3 | 0.799 |
CDK3 |
0.742 | 0.159 | 1 | 0.676 |
P70S6KB |
0.742 | 0.026 | -3 | 0.826 |
LATS1 |
0.742 | 0.079 | -3 | 0.859 |
PKACG |
0.742 | -0.008 | -2 | 0.345 |
PKCD |
0.742 | 0.032 | 2 | 0.665 |
BRSK1 |
0.742 | 0.130 | -3 | 0.827 |
CAMK2B |
0.742 | 0.044 | 2 | 0.671 |
TGFBR1 |
0.741 | 0.030 | -2 | 0.460 |
CAMK2G |
0.741 | -0.084 | 2 | 0.677 |
CDK9 |
0.741 | 0.155 | 1 | 0.736 |
CDK12 |
0.741 | 0.151 | 1 | 0.714 |
CDK16 |
0.740 | 0.166 | 1 | 0.668 |
MARK3 |
0.740 | 0.158 | 4 | 0.733 |
PRKX |
0.739 | 0.051 | -3 | 0.764 |
PKCB |
0.739 | 0.054 | 2 | 0.625 |
MNK2 |
0.739 | 0.024 | -2 | 0.398 |
FAM20C |
0.738 | 0.050 | 2 | 0.582 |
NUAK1 |
0.738 | 0.068 | -3 | 0.822 |
GRK5 |
0.738 | -0.124 | -3 | 0.803 |
MLK1 |
0.738 | -0.090 | 2 | 0.696 |
AKT2 |
0.738 | 0.088 | -3 | 0.756 |
PKG2 |
0.738 | 0.014 | -2 | 0.310 |
NEK7 |
0.738 | -0.093 | -3 | 0.772 |
PAK1 |
0.738 | -0.001 | -2 | 0.399 |
PHKG1 |
0.737 | 0.033 | -3 | 0.847 |
DYRK3 |
0.737 | 0.145 | 1 | 0.783 |
RIPK3 |
0.737 | -0.096 | 3 | 0.710 |
MARK2 |
0.736 | 0.132 | 4 | 0.709 |
NEK9 |
0.736 | -0.025 | 2 | 0.702 |
BCKDK |
0.736 | -0.085 | -1 | 0.773 |
ALK4 |
0.736 | -0.008 | -2 | 0.469 |
MLK3 |
0.736 | -0.018 | 2 | 0.639 |
PAK3 |
0.735 | -0.012 | -2 | 0.401 |
BRSK2 |
0.735 | 0.083 | -3 | 0.828 |
MSK2 |
0.735 | 0.027 | -3 | 0.789 |
NIM1 |
0.735 | 0.019 | 3 | 0.708 |
MSK1 |
0.735 | 0.034 | -3 | 0.796 |
DLK |
0.735 | -0.094 | 1 | 0.752 |
MASTL |
0.734 | -0.118 | -2 | 0.421 |
SGK3 |
0.734 | 0.077 | -3 | 0.812 |
CHK1 |
0.734 | 0.062 | -3 | 0.834 |
PRP4 |
0.734 | 0.106 | -3 | 0.711 |
AURB |
0.734 | -0.026 | -2 | 0.285 |
QIK |
0.733 | 0.036 | -3 | 0.825 |
CDK10 |
0.733 | 0.143 | 1 | 0.711 |
PKCA |
0.733 | 0.018 | 2 | 0.620 |
ACVR2B |
0.733 | -0.004 | -2 | 0.446 |
ERK2 |
0.733 | 0.112 | 1 | 0.742 |
MELK |
0.733 | 0.043 | -3 | 0.831 |
GRK7 |
0.732 | -0.021 | 1 | 0.694 |
BMPR1A |
0.732 | 0.039 | 1 | 0.743 |
MOK |
0.732 | 0.177 | 1 | 0.761 |
PKCG |
0.731 | -0.003 | 2 | 0.619 |
CDK14 |
0.731 | 0.130 | 1 | 0.720 |
PKACA |
0.731 | 0.031 | -2 | 0.286 |
ULK1 |
0.731 | -0.109 | -3 | 0.725 |
GRK6 |
0.731 | -0.085 | 1 | 0.757 |
PIM2 |
0.731 | 0.049 | -3 | 0.793 |
JNK1 |
0.731 | 0.174 | 1 | 0.708 |
MNK1 |
0.730 | 0.002 | -2 | 0.402 |
AURA |
0.730 | -0.035 | -2 | 0.262 |
TLK2 |
0.730 | -0.010 | 1 | 0.701 |
CDK2 |
0.730 | 0.071 | 1 | 0.771 |
MYLK4 |
0.730 | 0.005 | -2 | 0.387 |
HUNK |
0.730 | -0.087 | 2 | 0.642 |
YSK4 |
0.730 | -0.028 | 1 | 0.699 |
SSTK |
0.729 | 0.122 | 4 | 0.730 |
PKR |
0.729 | -0.008 | 1 | 0.735 |
ALK2 |
0.729 | -0.021 | -2 | 0.443 |
DCAMKL1 |
0.729 | 0.078 | -3 | 0.834 |
ACVR2A |
0.729 | -0.039 | -2 | 0.424 |
ANKRD3 |
0.728 | -0.121 | 1 | 0.740 |
MPSK1 |
0.728 | 0.105 | 1 | 0.666 |
PAK6 |
0.728 | -0.010 | -2 | 0.335 |
MEK1 |
0.728 | -0.061 | 2 | 0.726 |
IRE1 |
0.728 | -0.067 | 1 | 0.684 |
PKCZ |
0.727 | -0.018 | 2 | 0.657 |
CAMK4 |
0.727 | -0.068 | -3 | 0.831 |
ATM |
0.727 | -0.048 | 1 | 0.654 |
VRK2 |
0.727 | -0.028 | 1 | 0.782 |
MAPKAPK5 |
0.727 | 0.042 | -3 | 0.756 |
DNAPK |
0.727 | 0.010 | 1 | 0.624 |
WNK3 |
0.726 | -0.162 | 1 | 0.710 |
MARK1 |
0.726 | 0.084 | 4 | 0.739 |
GSK3A |
0.726 | 0.069 | 4 | 0.445 |
PKCH |
0.726 | -0.018 | 2 | 0.597 |
CHAK1 |
0.725 | -0.039 | 2 | 0.697 |
GRK4 |
0.725 | -0.151 | -2 | 0.414 |
RIPK1 |
0.724 | -0.145 | 1 | 0.702 |
IRE2 |
0.724 | -0.067 | 2 | 0.597 |
NEK2 |
0.724 | -0.002 | 2 | 0.696 |
MLK4 |
0.723 | -0.077 | 2 | 0.614 |
TTBK2 |
0.723 | -0.138 | 2 | 0.559 |
AKT1 |
0.723 | 0.053 | -3 | 0.775 |
PLK1 |
0.722 | -0.127 | -2 | 0.406 |
GRK2 |
0.722 | -0.070 | -2 | 0.367 |
MST3 |
0.721 | 0.022 | 2 | 0.727 |
PAK2 |
0.721 | -0.075 | -2 | 0.372 |
ERK7 |
0.721 | 0.056 | 2 | 0.468 |
PASK |
0.721 | 0.051 | -3 | 0.867 |
AKT3 |
0.721 | 0.076 | -3 | 0.716 |
SMG1 |
0.721 | -0.042 | 1 | 0.661 |
CK1E |
0.721 | 0.008 | -3 | 0.524 |
SNRK |
0.719 | -0.055 | 2 | 0.556 |
BRAF |
0.719 | -0.037 | -4 | 0.673 |
SGK1 |
0.718 | 0.093 | -3 | 0.698 |
TAO3 |
0.718 | 0.013 | 1 | 0.718 |
TLK1 |
0.718 | -0.054 | -2 | 0.477 |
GSK3B |
0.718 | 0.016 | 4 | 0.437 |
CDK4 |
0.718 | 0.130 | 1 | 0.703 |
DRAK1 |
0.718 | -0.046 | 1 | 0.693 |
SBK |
0.717 | 0.122 | -3 | 0.667 |
CDK6 |
0.717 | 0.121 | 1 | 0.699 |
PKCT |
0.717 | -0.004 | 2 | 0.608 |
DCAMKL2 |
0.717 | 0.021 | -3 | 0.835 |
P70S6K |
0.717 | 0.011 | -3 | 0.755 |
SMMLCK |
0.716 | -0.007 | -3 | 0.830 |
CAMK1D |
0.716 | 0.042 | -3 | 0.752 |
BUB1 |
0.716 | 0.094 | -5 | 0.744 |
NEK5 |
0.716 | -0.017 | 1 | 0.700 |
DAPK3 |
0.715 | 0.038 | -3 | 0.836 |
ZAK |
0.715 | -0.087 | 1 | 0.705 |
MEK5 |
0.714 | -0.138 | 2 | 0.707 |
CAMK1G |
0.714 | -0.014 | -3 | 0.798 |
MEKK2 |
0.714 | -0.063 | 2 | 0.677 |
LKB1 |
0.713 | 0.045 | -3 | 0.777 |
PINK1 |
0.713 | -0.085 | 1 | 0.756 |
PERK |
0.713 | -0.141 | -2 | 0.436 |
PKCE |
0.713 | 0.015 | 2 | 0.605 |
MEKK1 |
0.712 | -0.094 | 1 | 0.705 |
PLK3 |
0.712 | -0.123 | 2 | 0.628 |
WNK4 |
0.712 | -0.049 | -2 | 0.482 |
PHKG2 |
0.712 | -0.025 | -3 | 0.819 |
MAP3K15 |
0.712 | 0.083 | 1 | 0.686 |
HRI |
0.711 | -0.143 | -2 | 0.460 |
CK1G1 |
0.711 | -0.003 | -3 | 0.516 |
PLK4 |
0.711 | -0.101 | 2 | 0.478 |
CHK2 |
0.711 | 0.075 | -3 | 0.712 |
PKCI |
0.711 | -0.033 | 2 | 0.625 |
CK1D |
0.710 | -0.015 | -3 | 0.476 |
IRAK4 |
0.710 | -0.064 | 1 | 0.676 |
KHS1 |
0.710 | 0.109 | 1 | 0.713 |
GCK |
0.710 | 0.029 | 1 | 0.738 |
PKN1 |
0.710 | 0.037 | -3 | 0.768 |
PDK1 |
0.709 | 0.029 | 1 | 0.698 |
DAPK1 |
0.709 | 0.031 | -3 | 0.819 |
TNIK |
0.709 | 0.065 | 3 | 0.796 |
PAK5 |
0.708 | -0.053 | -2 | 0.282 |
MEKK6 |
0.708 | 0.032 | 1 | 0.705 |
PDHK3_TYR |
0.708 | 0.193 | 4 | 0.820 |
MEKK3 |
0.708 | -0.170 | 1 | 0.722 |
GRK3 |
0.708 | -0.077 | -2 | 0.337 |
CAMKK2 |
0.708 | -0.068 | -2 | 0.395 |
HGK |
0.708 | 0.028 | 3 | 0.802 |
CAMK1A |
0.707 | 0.055 | -3 | 0.736 |
HPK1 |
0.707 | 0.034 | 1 | 0.727 |
MST2 |
0.706 | -0.042 | 1 | 0.726 |
NEK11 |
0.706 | -0.063 | 1 | 0.713 |
CAMKK1 |
0.706 | -0.112 | -2 | 0.393 |
MINK |
0.706 | 0.026 | 1 | 0.713 |
TAO2 |
0.706 | -0.054 | 2 | 0.719 |
PAK4 |
0.706 | -0.049 | -2 | 0.282 |
CK1A2 |
0.705 | -0.015 | -3 | 0.482 |
ROCK2 |
0.705 | 0.030 | -3 | 0.824 |
MRCKB |
0.704 | 0.013 | -3 | 0.787 |
NEK4 |
0.704 | -0.041 | 1 | 0.689 |
KHS2 |
0.702 | 0.054 | 1 | 0.730 |
EEF2K |
0.702 | -0.035 | 3 | 0.744 |
GAK |
0.701 | -0.073 | 1 | 0.705 |
LOK |
0.701 | -0.035 | -2 | 0.375 |
CK2A2 |
0.700 | -0.032 | 1 | 0.673 |
MRCKA |
0.700 | -0.010 | -3 | 0.797 |
NEK8 |
0.699 | -0.157 | 2 | 0.685 |
LRRK2 |
0.699 | -0.057 | 2 | 0.711 |
TAK1 |
0.699 | -0.066 | 1 | 0.732 |
MAP2K4_TYR |
0.699 | 0.069 | -1 | 0.860 |
NEK1 |
0.698 | -0.022 | 1 | 0.680 |
PKG1 |
0.698 | -0.020 | -2 | 0.249 |
LIMK2_TYR |
0.698 | 0.097 | -3 | 0.854 |
DMPK1 |
0.698 | 0.028 | -3 | 0.815 |
TESK1_TYR |
0.697 | 0.028 | 3 | 0.805 |
SLK |
0.697 | -0.072 | -2 | 0.340 |
PKMYT1_TYR |
0.696 | 0.064 | 3 | 0.805 |
MST1 |
0.696 | -0.069 | 1 | 0.709 |
PBK |
0.695 | -0.014 | 1 | 0.619 |
IRAK1 |
0.695 | -0.164 | -1 | 0.714 |
MAP2K6_TYR |
0.695 | 0.007 | -1 | 0.863 |
YSK1 |
0.694 | -0.030 | 2 | 0.692 |
CRIK |
0.694 | 0.046 | -3 | 0.776 |
VRK1 |
0.694 | -0.083 | 2 | 0.666 |
HASPIN |
0.694 | 0.051 | -1 | 0.647 |
PDHK4_TYR |
0.693 | -0.026 | 2 | 0.771 |
PDHK1_TYR |
0.693 | 0.045 | -1 | 0.871 |
TTBK1 |
0.691 | -0.173 | 2 | 0.479 |
PLK2 |
0.691 | -0.084 | -3 | 0.694 |
MEK2 |
0.690 | -0.129 | 2 | 0.692 |
ROCK1 |
0.690 | 0.005 | -3 | 0.798 |
CK2A1 |
0.690 | -0.044 | 1 | 0.658 |
OSR1 |
0.690 | -0.050 | 2 | 0.699 |
EPHA6 |
0.689 | 0.077 | -1 | 0.819 |
BMPR2_TYR |
0.689 | -0.028 | -1 | 0.835 |
MAP2K7_TYR |
0.689 | -0.126 | 2 | 0.732 |
ABL2 |
0.686 | 0.045 | -1 | 0.802 |
ROS1 |
0.686 | 0.014 | 3 | 0.743 |
STK33 |
0.685 | -0.128 | 2 | 0.494 |
NEK3 |
0.685 | -0.073 | 1 | 0.662 |
TXK |
0.685 | 0.048 | 1 | 0.746 |
ASK1 |
0.685 | 0.016 | 1 | 0.676 |
TTK |
0.685 | -0.086 | -2 | 0.415 |
LIMK1_TYR |
0.684 | -0.062 | 2 | 0.724 |
CSF1R |
0.684 | 0.006 | 3 | 0.762 |
EPHB4 |
0.684 | 0.028 | -1 | 0.799 |
MYO3B |
0.684 | -0.013 | 2 | 0.719 |
RET |
0.683 | -0.045 | 1 | 0.705 |
ABL1 |
0.683 | 0.029 | -1 | 0.797 |
JAK2 |
0.683 | -0.010 | 1 | 0.704 |
PINK1_TYR |
0.683 | -0.158 | 1 | 0.743 |
CK1A |
0.683 | -0.018 | -3 | 0.396 |
RIPK2 |
0.682 | -0.209 | 1 | 0.656 |
JAK1 |
0.681 | 0.054 | 1 | 0.668 |
MYO3A |
0.680 | -0.043 | 1 | 0.706 |
TYK2 |
0.680 | -0.068 | 1 | 0.697 |
FGR |
0.680 | -0.049 | 1 | 0.708 |
TYRO3 |
0.679 | -0.067 | 3 | 0.760 |
TNNI3K_TYR |
0.679 | 0.047 | 1 | 0.725 |
TNK2 |
0.679 | 0.024 | 3 | 0.733 |
MST1R |
0.678 | -0.078 | 3 | 0.778 |
TAO1 |
0.678 | -0.051 | 1 | 0.654 |
JAK3 |
0.677 | -0.056 | 1 | 0.695 |
DDR1 |
0.676 | -0.069 | 4 | 0.714 |
NEK10_TYR |
0.676 | -0.007 | 1 | 0.598 |
LCK |
0.675 | -0.009 | -1 | 0.808 |
SRMS |
0.675 | -0.025 | 1 | 0.746 |
INSRR |
0.675 | -0.063 | 3 | 0.691 |
EPHA4 |
0.675 | -0.029 | 2 | 0.638 |
ITK |
0.675 | -0.030 | -1 | 0.770 |
YES1 |
0.674 | -0.060 | -1 | 0.832 |
YANK3 |
0.674 | -0.066 | 2 | 0.306 |
BIKE |
0.674 | -0.054 | 1 | 0.574 |
FER |
0.673 | -0.084 | 1 | 0.748 |
BLK |
0.673 | 0.003 | -1 | 0.819 |
HCK |
0.672 | -0.046 | -1 | 0.806 |
KIT |
0.672 | -0.063 | 3 | 0.758 |
EPHB1 |
0.670 | -0.047 | 1 | 0.747 |
TNK1 |
0.670 | -0.029 | 3 | 0.748 |
PDGFRB |
0.669 | -0.104 | 3 | 0.768 |
EPHB2 |
0.669 | -0.030 | -1 | 0.781 |
KDR |
0.669 | -0.086 | 3 | 0.721 |
EPHB3 |
0.669 | -0.040 | -1 | 0.785 |
FGFR2 |
0.668 | -0.110 | 3 | 0.730 |
BMX |
0.667 | -0.030 | -1 | 0.692 |
MERTK |
0.667 | -0.055 | 3 | 0.723 |
AAK1 |
0.667 | -0.009 | 1 | 0.480 |
DDR2 |
0.667 | -0.001 | 3 | 0.691 |
ALPHAK3 |
0.666 | -0.093 | -1 | 0.751 |
MET |
0.666 | -0.073 | 3 | 0.749 |
FGFR1 |
0.666 | -0.090 | 3 | 0.719 |
ALK |
0.665 | -0.054 | 3 | 0.693 |
TEK |
0.665 | -0.108 | 3 | 0.693 |
TEC |
0.665 | -0.059 | -1 | 0.714 |
AXL |
0.665 | -0.081 | 3 | 0.730 |
STLK3 |
0.664 | -0.125 | 1 | 0.669 |
EPHA7 |
0.664 | -0.032 | 2 | 0.632 |
FLT3 |
0.663 | -0.142 | 3 | 0.763 |
PDGFRA |
0.663 | -0.122 | 3 | 0.768 |
FYN |
0.663 | -0.041 | -1 | 0.793 |
PTK2B |
0.663 | -0.021 | -1 | 0.762 |
LTK |
0.662 | -0.072 | 3 | 0.719 |
BTK |
0.660 | -0.123 | -1 | 0.732 |
FRK |
0.660 | -0.063 | -1 | 0.818 |
EPHA1 |
0.659 | -0.054 | 3 | 0.731 |
PTK6 |
0.659 | -0.118 | -1 | 0.720 |
EPHA3 |
0.658 | -0.093 | 2 | 0.606 |
NTRK1 |
0.658 | -0.141 | -1 | 0.800 |
LYN |
0.658 | -0.074 | 3 | 0.705 |
NTRK3 |
0.657 | -0.080 | -1 | 0.764 |
FGFR3 |
0.657 | -0.124 | 3 | 0.699 |
FLT1 |
0.657 | -0.129 | -1 | 0.807 |
INSR |
0.657 | -0.102 | 3 | 0.686 |
ERBB2 |
0.655 | -0.139 | 1 | 0.678 |
CSK |
0.654 | -0.070 | 2 | 0.635 |
EPHA8 |
0.654 | -0.061 | -1 | 0.777 |
MATK |
0.654 | -0.091 | -1 | 0.731 |
NTRK2 |
0.653 | -0.156 | 3 | 0.710 |
FLT4 |
0.653 | -0.153 | 3 | 0.711 |
SRC |
0.653 | -0.072 | -1 | 0.801 |
EPHA5 |
0.653 | -0.078 | 2 | 0.620 |
WEE1_TYR |
0.653 | -0.123 | -1 | 0.703 |
EGFR |
0.651 | -0.077 | 1 | 0.592 |
SYK |
0.651 | -0.055 | -1 | 0.754 |
PTK2 |
0.650 | -0.039 | -1 | 0.738 |
FGFR4 |
0.647 | -0.089 | -1 | 0.758 |
ERBB4 |
0.647 | -0.044 | 1 | 0.617 |
YANK2 |
0.644 | -0.089 | 2 | 0.326 |
CK1G3 |
0.642 | -0.072 | -3 | 0.357 |
EPHA2 |
0.642 | -0.078 | -1 | 0.735 |
IGF1R |
0.641 | -0.116 | 3 | 0.624 |
MUSK |
0.639 | -0.117 | 1 | 0.559 |
CK1G2 |
0.636 | -0.080 | -3 | 0.442 |
ZAP70 |
0.634 | -0.059 | -1 | 0.674 |
FES |
0.629 | -0.101 | -1 | 0.679 |